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ABSTRACT OF THE DISSERTATION
The Role of Gene Transcription and Inflammatory Cytokines in Bone Fracture Repair
by
Brandon Coates
Doctor of Philosophy in Biomedical Engineering
Washington University in St. Louis, 2020
Professor Matthew Silva, Chair

In most instances, the skeleton has a remarkable capacity for repair following injury.
However, in 5 to 10% of patients, fractures fail to properly heal resulting in non-union. A need
exists for a more comprehensive understanding of the complex biology of fracture repair, which
involves the coordinated work of many cell types including osteoblasts, osteoclasts, and immune
cells. Depending on the extent of injury, fractures will heal through either intramembranous bone
formation, involving the direct formation of bone callus, or endochondral bone formation,
featuring a cartilage intermediary prior to bone callus formation. Both processes begin with
inflammation, which sets the stage for a successful repair cascade. However, the production of
inflammatory cytokines and recruitment of immune cells in the early stages of fracture repair,
and the implications for these processes on effective fracture repair remain incompletely
understood.
For the first aim of the dissertation, we examined gene expression in response to injury
across a broad range of time points for both intramembranous and endochondral bone formation.
We used RNA sequencing to observe gene expression and immunohistochemistry to observe
select protein expression throughout the early repair process. While some degree of overlap
xi

existed, we observed divergent gene expression between intramembranous and endochondral
bone formation, with each possessing a distinct transcriptome contributing to repair. An
inflammatory reaction was present for both bone formation types, however endochondral repair
had expression of inflammatory genes and recruitment of immune cells that were orders of
magnitude greater than observed in intramembranous repair. Intramembranous repair was more
enriched for genes associated with osteoblasts and bone formation and was uniquely enriched for
PI3K-Akt signaling. This is likely reflective of the more simplified nature of bone formation in
intramembranous repair – which does not require production of a cartilage intermediary callus.
We also observed a dramatic downregulation of voltage gated ion channels in endochondral
repair, which was not present in intramembranous repair.
For the second aim of this dissertation, we tested the involvement of interleukin-6 (IL-6)
in fracture repair. IL-6 is a component of the inflammatory reaction to skeletal injury and has
high upregulation in early callus tissue. We used an IL-6 global knockout mouse (IL-6 KO) with
two models of skeletal injury, full fracture and stress fracture, which heal through endochondral
and intramembranous bone formation respectively. Full fracture repair was not altered in IL-6
KO mice. However, repair of stress fracture was enhanced in IL-6 KO mice, which had larger
calluses and more bone formation than control animals. IL-6 KO did not alter osteoclast numbers
or recruitment of the innate immune system in stress fracture callus. IL-6 KO mice had slight
reductions in inflammatory signaling and higher expression of the bone anabolic protein Wnt1
after injury. Furthermore, IL-6 KO animals displayed an increased ability to form woven bone
when challenged with a non-injurious model of loading induced bone formation. Thus IL-6 KO
directly affects the bone building potential of osteoblasts, allowing for the increased formation of
bone.
xii

For the third aim of this dissertation, we examined the CXC family of chemokines in
skeletal repair through deletion of CXC family receptor 2 (Cxcr2). Several members of the CXC
chemokine family are among the most highly upregulated genes following skeletal injury.
Despite this, their impact of fracture repair has not been reported. We used a global knockout
mouse for Cxcr2 (Cxcr2 KO) to study bone formation after full and stress fracture. The ability of
Cxcr2 KO mice to form bone was unchanged following full fracture. However, after stress
fracture Cxcr2 KO mice had a diminished capacity for repair, producing smaller calluses with
less bone formation than control animals. Cxcr2 KO mice had blunted recruitment of
neutrophils, the earliest responding immune cell to injury, within stress fracture callus. Thus, we
concluded that the blunted immune response in Cxcr2 KO mice leads to the reduced capacity for
bone formation.
This dissertation work provides insight into the transcriptional profile and inflammatory
response of fracture repair following skeletal injury. We are hopeful that this work will benefit
the planning of future research on fracture repair biology and provide insight for potential
fracture therapeutics to aid in repair and prevent nonunion.
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Chapter 1: Overview of Fracture Repair and
Inflammation

1.1 The Skeleton and Bone Cells
Bone is a dynamic tissue that is continually remodeling to repair and replace old and
damaged matrix. The main cell populations in bone include osteoblasts, osteoclasts, and
osteocytes (Figure 1.1). Osteoblasts are bone cells from the mesenchymal lineage whose main
role is the production of bone matrix [1]. Osteoclasts are multinucleated cells from the myeloid
lineage which use enzymes to digest bone matrix [1]. Osteocytes are terminally differentiated
osteoblasts which reside in the bone matrix and orchestrate the activities of osteoblasts and
osteoclasts [2]. Bone remodeling is a coordinating activity which begins with osteoclasts
removing damaged and old matrix and osteoblasts laying down replacement matrix [3]. Bone
quality and quantity are both determined by the remodeling process, the proper balance of which
helps protect the skeleton from the risk of fracture.

1

Figure 1.1: Overview of Bone Cells and Their Roles in Skeletal Remodeling.
Osteoblasts reside on the bone surface and form new bone matrix. Osteoclasts
also reside on the bone surface and digest and remove bone matrix. Osteocytes
reside within the bone matrix and direct the activities of the osteoblasts and
osteoclasts. Bone remodeling is a tightly coupled process involving all three of
these cell types and must be balanced to maintain proper bone quality and
quantity. Figure adapted from [4].

The skeleton consists of two distinct kinds of bone, cancellous and cortical (Figure 1.2).
Cancellous bone, which resides primarily at the ends of long bones and within the vertebra, is
spongy in design and is composed of small trabecular struts and rods. Cortical bone, which
constitutes most of the length of long bones, is densely packed and organized bone. The cortical
bone has two surfaces, the internal surface which faces the medullary space is covered by the
endosteum, a thin fibrous layer. The periosteum covers the external surface of the bone and also
serves as a reserve of osteoprogenitor cells which aid in skeletal maintenance and response to
injury [4].

2

Figure 1.2: Overview of Skeletal Anatomy. The long bones of the skeleton are comprised of
cancellous bone and cortical bone. Cancellous bone is the porous bone comprised of small strut like
trabeculae and is primary located at the ends of the bone in the epiphysis and metaphysis regions.
Cortical bone is densely packed bone which constitutes the middle portion of the long bones. Figure
adapted from [6].
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1.2 Overview of the Fracture Repair Process
Microdamage in bone tissue can occur through mechanical loading resulting from normal
activity. This damage is typically repaired through skeletal remodeling. However, in events such
as trauma or overuse, where damage formation outpaces remodeling, skeletal fractures will
develop.
Bone has a remarkable capacity for regeneration, which can occur through two different
mechanisms – endochondral ossification or intramembranous ossification (Figure 1.3).
Endochondral ossification is believed to recapitulate the developmental process of long bone
formation and features an initial inflammatory reaction, formation of a cartilage based
intermediary soft callus, transition from the soft callus to a boney hard callus, and finally
remodeling of the hard callus back to the original morphology of the pre-injury bone (Figure 1.3
A) [5]. On the other hand, intramembranous ossification is thought to recapitulate the
development of the skull and craniofacial bones and features an inflammatory reaction, direct
formation of a bone hard callus without a cartilage intermediary, and finally resolution of
regeneration by remodeling of the callus back to the original morphology of bone (Figure 1.3 B)
[6].
Two mechanisms help determine whether intramembranous or endochondral ossification
occur following injury [7]. The first consideration is stability of the injury site. Injuries with
greater stability will heal through intramembranous ossification. However, injuries with less
mechanical stability heal through endochondral ossification. The second consideration (which
also contributes to mechanical stability) is the amount of displacement generated by the injury. If
the bone suffers no displacement, or undergoes surgical reduction to restore original anatomy, it
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will be predisposed to intramembranous ossification [6]. However, if injury results in
displacement between bone fragments, then endochondral bone formation is the most likely
healing method.

Figure 1.3: Endochondral and Intramembranous Ossification. Endochondral ossification (A) is the response to
injuries causing displacement of the bone ends and mechanical instability. Endochondral repair begins with
inflammation, soft callus formation, hard callus formation, and concludes with remodeling. Intramembranous
ossification (B) is the response to injuries that cause little displacement of bone ends and are mechanically stable.
Intramembranous repair begins with inflammation, followed by direct formation of a hard callus, and concludes with
remodeling.
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1.3 The Inflammatory Phase of Fracture Repair
Inflammation is the first response of the skeleton to damage and begins immediately
following injury. During the inflammatory phase, the release of cytokines govern the earliest
repair processes, including the recruitment of various types of immune cells which play a vital
role in early fracture repair. Despite its importance in triggering the cascade of crucial healing
events, this inflammatory response remains incompletely understood.
The inflammatory reaction involves a series of processes beginning with formation of a
hematoma [8]. Immune cells are recruited to the injury site beginning immediately after injury.
The first immune cells to arrive are neutrophils which dominate the earliest response [9].
Following neutrophils, monocytes and macrophages begin to arrive to the injured area [9].
Together, these cells help remove the fibrous matrix of the hematoma and any necrotic cells
damaged from the injury [8]. The next phase of recruitment includes cells of the adaptive
immune system and progenitors of osteoblasts and osteoclasts. Finally, the inflammatory
reaction is resolved as the repair process moves into anabolic phases of callus formation [10].
This inflammatory phase sets the stage for a successful repair cascade and must be tightly
controlled both in extent and time course. An imbalanced inflammatory reaction will lead to suboptimal healing [10,11]. An inflammatory reaction which is too great can be detrimental to healing.
This has been shown clinically in reports of hyper-inflammation in patients with polytrauma
[12,13], obesity [14], or diabetes [15,16]. Conversely, an inflammatory reaction which is
insufficiently strong will also lead to sub-optimal repair. This has been reported clinically in
patients with HIV [17] and those treated with nonsteroidal anti-inflammatory drugs [18–20].

6

Therefore, a high clinical importance exists for a thorough understanding of the inflammatory
phase of fracture healing and how it facilitates a successful repair cascade.
Recruitment of immune cells to the site of fracture plays an important role in the
inflammatory phase of repair. Neutrophils are the first responding immune cells to skeletal injury
and their absence results in sub-optimal repair [21]. Following neutrophils are monocytes and
macrophages. Various subsets of macrophages play distinct roles in fracture repair. Depletion of
bone resident macrophages reduced callus formation and bone deposition in a tibia fracture
model [22]. M1 type macrophages help promote mineralization via oncostatin M production in a
tibia injury model [23]. Finally, increasing the level of M2 macrophages in the fracture callus
enhanced bone formation in a femur osteotomy model [24]. These innate immune cells help to
activate the adaptive immune system, which also plays a role in fracture repair through by
production and suppression of various cytokines [25–27].
Facilitating this inflammatory stage are a mix of cytokines and chemokines which are
released in response to skeletal injury. Some of the most upregulated genes following skeletal
injury include inflammatory cytokines such as interleukin-6 (IL-6), interleukin-1 (IL-1),
prostaglandin-2 (Ptgs2), and members of the CXC family of chemokines (Cxcl1, Cxcl2, Cxcl3,
& Cxcl5) [28,29]. The role that some of these factors play in fracture repair has been well
documented. For example, Ptgs2 (aka Cox-2) has been shown to be a vital component of repair,
with Cox-2 null mice having failed healing [30,31]. IL-1 has also been well studied in fracture,
and likely plays important roles in hematoma development and osteoblast proliferation [32,33].
The roles that IL-6 and CXC family chemokines play in fracture repair are less understood.
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The role of IL-6 in fracture repair has been reported to delay repair [34,35]. In particular,
Yang et al describe that IL-6 null mice had reduced mineral content and increased cartilage
content in fracture callus two weeks after a femur osteotomy [34]. These differences were not
detected at six weeks post injury. Similarly, Wallace et al report IL-6 null mice to have reduced
biomechanics of fracture callus two weeks after tibia fracture [35]. These differences were also
absent by six weeks post-injury. In total, these reports indicate that knockout of IL-6 delays
repair of full fractures. However, neither of these studies investigated changes in the
inflammatory phase in the context of IL-6 knockout. Furthermore, both of these studies used
models which primarily repair through endochondral ossification, leaving the impact of IL-6
knockout on intramembranous repair unstudied.
How the CXC family of chemokines contribute to fracture repair has not been thoroughly
explored. A study of CXC receptor two (Cxcr2) null mice suggest a role for this family in bone
development and skeletal repair [36]. Bischoff et al. report Cxcr2 null mice had smaller body
weights and body length. MicroCT analysis revealed reduced trabecular and cortical bone
density revealing a potential role for Cxcr2 in skeletal development. These investigators used a
cranial defect model to probe how Cxcr2 knockout impacts skeletal repair. They report a reduced
capacity for bone formation in knockout mice suggesting a putative role for Cxcr2 in skeletal
repair.
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1.4 Non-Union Fractures and Clinical Implications
Skeletal fractures embody a substantial clinical problem. About 16 million fractures
occur annually in the U.S. – equating to a fractured bone every 2 seconds [37]. Most of these
injuries will heal without major complications. However, an estimated 5 to 10% of fractures will
result in non-union [38]. Non-unions are fractures that never successfully repair and are unable
to regain the mechanical stability of intact bone. They are defined as the cessation of the repair
process without a bridging of the fracture gap [39]. Non-unions require additional interventions
by clinicians and are often treated through complicated surgical procedures [40]. Many
comorbidities are associated with non-unions, including general risk factors such as old age, poor
diet, and cigarette smoking, and local risk factors such as fracture type, infection, and polytrauma
[41]. However, the precise pathogenesis of non-unions remains elusive and could be a failure of
any of the several key phases of repair.
The medical treatment of fractures and non-unions represent a sizeable economic burden
on the healthcare system of the U.S. The direct treatment of fractures is estimated to cost $40
billion in the U.S. each year [42]. Non-unions typically cost more than twice as much to
effectively treat as union fractures [40]. It is estimated that 60 million work days are lost
annually due to fracture – an amount more than double what is lost to heart disease and stroke
combined [42]. Beyond the economics, fractures have an incredibly detrimental effect on overall
health. This is especially true in elderly patients. Following an osteoporotic fracture, patients
have increased morbidity, mortality, and subsequent fracture risks [43].
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Therefore, a clinical need exists for a better understanding of the complex biology of
fracture repair. Preclinical evaluations which provide insight into post-injury bone formation
could be very valuable and may better inform clinical decisions and interventions for fractures
and non-unions.

1.5 Animal Models of Fracture Repair
In order to study the complex biological processes involved in fracture repair, animal
models are commonly used. In particular, murine models of fracture are useful due to the
widespread use of transgenic animals which provide the ability to study the involvement of
specific genes and cell types in fracture repair.
Our research group commonly uses two different skeletal injury models in order to study
bone formation (Figure 1.4). In order to examine endochondral ossification, we use a murine
femur full fracture model [28,44]. This model is defined by a transverse, fully displaced crack
across the mid-diaphysis of the femur initiated through overt overloading of the bone by 3-pt
bending. This injury proceeds through the various phases of endochondral repair, including
inflammation, soft callus, hard callus, and remodeling.
To study intramembranous ossification, we use a murine ulna stress fracture model. This
model is defined by an oblique, non-displaced crack within the diaphysis of the ulna. Cyclic
loading is used to initiate the crack through fatigue. This injury proceeds through the various
phases of intramembranous repair.

10

Figure 1.4: Skeletal Injury Models. Full fractures were created using 3-point bending. MicroCT reconstruction 14
days after fracture depicts woven bone (Wo.B) formation in the callus surrounding injury site. Longitudinal histology
image of day 14 full fracture callus, stained with hematoxylin and eosin shows original cortical bone (Ct), woven
bone and cartilage (Cg) in the callus surrounding the original crack (▲). Stress fractures were created using cyclic
fatigue of the mouse ulna. MicroCT reconstruction depicts woven bone formation surrounding crack at day 7.
Longitudinal histology of day 7 stress fracture callus shows woven bone formation in callus around original crack
(▲).
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1.6 Goals of the Dissertation
The treatment of skeletal fractures and non-unions represent an important clinical challenge.
A need exists for more basic science research which will help detail the complex biology of
fracture repair. This dissertation will seek to 1) Describe gene expression across several time
points for two types of skeletal repair and 2) investigate how interleukin-6 and CXC family
chemokines contribute to osteogenesis as components of the inflammatory phase of fracture
repair. By better understanding how gene expression is altered during intramembranous and
endochondral ossification, we hope to document the important genes and signaling pathways
which are critical to each repair modality and provide inspiration for more detailed examination
of these models. Through exploration of IL-6 and the CXC family, we hope to better understand
the inflammatory phase of fracture repair and how it contributes to successful repair.
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Chapter 2: A Forelimb Fatigue Model to
Study Damage and Repair in
Ovariectomized Rabbits
2.1 Abstract
Microdamage accumulates in bone matrix from normal activity and is repaired through
bone remodeling. Conditions such as osteoporosis and treatment with antiresorptives, such as
bisphosphonates, can influence this remodeling process. In order to study microdamage accrual
and repair in the context of osteoporosis and Haversian bone microstructure, we set out to
modify the rabbit forelimb fatigue model. New Zealand white rabbits received either
ovariectomy (OVX) or sham surgeries and were used for forelimb fatigue loading. OVX was
confirmed to induce increased intracortical and periosteal bone labeling as seen in dynamic
histomorphometry of the ulna, although bone mass was not affected. OVX and sham animals
were compared in non-survival fatigue loading for monotonic and cyclic loading parameters and
were found to have similar mechanical characteristics. Two levels of fatigue loading were then
used on OVX rabbit forelimbs to examine if dose dependent microdamage accrual could be
achieved. However, neither group showed increased damage burden as compared to non-loaded
controls. Survival fatigue loading was able to demonstrate increased intracortical remodeling and
periosteal lamellar bone formation in loaded limbs, although we did not observe basic
multicellular units or microdamage-targeted remodeling. In summary, we adapted the rabbit
forelimb fatigue model to accommodate OVX animals. However, loading parameters that could
induce repeatable microdamage burden were not identified. Thus, while increased intracortical
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remodeling and periosteal bone formation were induced by our fatigue loading regimen, we did
not establish conditions to allow future study of the interactions between microdamage accrual
and repair.

2.2 Introduction
During activities such as walking, running, and jumping, the skeleton withstands
mechanical loads and slowly accumulates microdamage within the bone matrix [45]. This
microdamage is eventually remodeled by osteoclasts and osteoblasts [46,47]. However, if
microdamage accrual is too rapid, or repair is too slow, microdamage can coalesce into
macrodamage, such as stress fractures and insufficiency fractures [48–50]. This balance can be
additionally complicated by osteoporosis, a disorder characterized by low bone mass afflicting
upwards of 200 million people worldwide [51]. Post-menopausal osteoporosis increases
resorption of bone matrix, thus altering a critical component of microdamage repair [52]. The
most common treatment for osteoporosis, bisphosphonate drugs, also alters the critical balance of
bone remodeling by limiting resorption. This can paradoxically increase risk for rare
complications such as atypical femoral fracture [53–56]. The interaction between osteoporosis,
damage accumulation, and remodeling suppression that contribute to atypical femur fractures is
not well understood. Animal models to study the balance between microdamage accrual and
repair, and how osteoporosis and bisphosphonates may alter this balance, could help address this
issue.
To date, the study of microdamage accrual and repair has primarily been conducted using
small rodent models [57–61]. However, we propose a rabbit model could be advantageous due to
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the presence of Haversian bone structures in rabbit cortical bone which more closely resemble
human bone morphology than mouse or rat [62,63]. These osteon bone structures are important
contributors of both where and how microdamage can accumulate and be repaired, and therefore
could be important components of a clinically relevant model [64,65]. Other desirable
characteristics of rabbits include their responsiveness to ovariectomy (OVX), an inducible model
for osteoporosis [66–68], and to common osteoporosis treatments, such as bisphosphonates [67–
69]. Using a rabbit model could provide the capability to study microdamage repair in osteonal,
osteoporotic, and bisphosphonate treated bone.
Preceding work from our group developed the rabbit axial forelimb compression model
as a tool for creating fatigue macrodamage/stress fracture [70]. While useful for the study of
stress fracture healing (injury response), this model needs further adaptation to be of use in the
study of pre-injury microdamage accrual and repair. Therefore, we set out to modify this model
for sub-fracture fatigue, in order to study microdamage accumulation and remodeling.
The goals of this work were to further develop a rabbit forelimb fatigue model which
could incorporate osteoporotic animals, induce repeatable and controllable amounts of
microdamage with sub-fracture fatigue loading, and to describe the intracortical repair response
following loading.
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2.3 Methods
2.3.1 Animals
Working within an IACUC approved protocol, a total of 43 female New Zealand White
rabbits (Covance) were used. Ovariectomy (OVX) or sham procedures were performed by
Covance on 6 month old rabbits. Animals were then shipped to Washington University and aged
4 months to allow osteoporotic effects to develop. Animals were single housed on a 12:12
light/dark schedule. At 10 months age, rabbits were used for experiments; average weight was
4.1 kg (± 0.4 kg) at time of experiments. OVX was confirmed at time of sacrifice through
reduction in uterine weight and absence of ovaries by visual inspection (Figure 2.1).

Figure 2.1: Confirmation of OVX by uterine weight. The uterus of each rabbit was dissected
at time of sacrifice and weighed. (A) Reduced weight in the OVX group was confirmation of
successful OVX induced estrogen withdrawal. (B) Body weight for the rabbits were consistent
across groups regardless of surgical group. Asterisk (*) denotes p < 0.05, n = 8-10/group.
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2.3.2 Forelimb Compression Model
All loading procedures were performed in vivo. Rabbits were administered anesthesia
(isoflurane) and were intubated and ventilated throughout the session. The forelimbs were
secured in a custom loading fixture at the olecranon and carpus on a material testing machine
(Instron Dynamight) as previously described [70]. After application of a 10 N pre-load,
monotonic or cyclic loading was applied through an actuator and forces were measured using a
load cell. For non-survival loading, animals were euthanized (sodium pentobarbital overdose,
150mg/kg i.v.) immediately following loading. For survival loading, animals were administered
buprenorphine (0.05 mg/kg, s.c.) for analgesia and were returned to normal cage activity until
sacrifice.

2.3.3 Experiment 1: Biomechanical Assessment
Eighteen rabbits (8 OVX, 10 Sham) were used to determine the effects of OVX on the
rabbit forelimb (Figure 2.2 A). For each rabbit, a non-survival bout of bilateral loading was
performed. One forelimb underwent monotonic loading and the other was subsequently used for
cyclic loading. For monotonic loading, a displacement ramp (0.5 mm/s) was applied until
complete fracture of the forelimb. Stiffness was calculated as the slope of the force-displacement
curve, ultimate force was the highest force reached during the test, and work to fracture was
calculated as the area under the force displacement curve (Figure 2.3 A).
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Figure 2.2: Experimental designs and timelines. For all studies, 6 month old female New Zealand white (NZW)
rabbits underwent either ovariectomy (OVX) or sham operation and were aged an additional 4 months before
beginning the experiment. (A) For Experiment 1, non-survival monotonic and fatigue loading was performed to
ascertain forelimb mechanics in OVX and sham animals. Bone structure and bone formation were assessed by
microCT and dynamic histomorphometry, respectively. (B) For Experiment 2, non-survival fatigue loading of
either “low” or “moderate” amounts was used to study microdamage accumulation in OVX bone. (C) For
Experiment 3, survival fatigue loading was used to study the response of the skeleton to moderate fatigue loading.
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Figure 2.3: Experiment 1 - Biomechanics of the rabbit forelimb under monotonic loading. (A) A typical
monotonic loading curve illustrating how stiffness, ultimate force, and work to fracture are obtained from the
force-displacement curve. Values for ultimate force (B), stiffness (C), and work to fracture (D) did not differ
between sham and OVX groups. n = 8-10/group.
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Cyclic loading was then performed until complete fracture by a force controlled haversine
wave (2 Hz) at 75% of the ultimate force from monotonic loading. Baseline stiffness (Kbaseline)
and baseline displacement (Dbaseline) were calculated at the tenth cycle, event 1 displacement
(DE1) was calculated at the inflection point of the displacement-time plot, and failure stiffness
(Kfail) and failure displacement (Dfail) were calculated at the last full cycle before fracture (Figure
2.4 A). Stiffness measurements were peak-to-peak displacement divided by applied force.
Displacement to event 1 was the distance between DE1 and Dbaseline, displacement to fracture was
the distance between Dfail and Dbaseline, and normalized fracture stiffness was the ratio of Kfail to
Kbaseline.
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Figure 2.4: Experiment 1 - Biomechanics of the rabbit forelimb under cyclic loading. (A) A typical cyclic loading
curve illustrating how baseline stiffness (Kbaseline), baseline displacement (Dbaseline), event 1 displacement (DE1), failure
stiffness (KFail), and failure displacement (DFail) are obtained from the displacement-cycle curve. Values for displacement
to Event 1 (B), displacement to fracture (C), and normalized fracture stiffness (D) did not differ between sham and OVX
groups. n = 8-10/group.
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2.3.4 Experiment 1: MicroCT Analysis
Following non-survival loading, forelimbs of OVX and sham-operated rabbits were
scanned at a region away from the damaged region using microCT (Scanco VivaCT). Dissected
ulnas were embedded in 3% agarose and imaged at 75 kVp, 300 ms integration time, and voxel
size of 17.5 μm. Analysis of the cortical bone was performed on 125 slices (2.2 mm) in the ulnar
diaphysis 30 mm distal to the olecranon, and analysis of the cancellous bone was performed on
125 slices in the proximal ulna beginning distal to the growth plate.

2.3.5 Experiment 1: Dynamic Histomorphometry
To assess baseline remodeling in OVX and Sham rabbits, calcein injections (10 mg/kg,
i.v.) were delivered at day 0 and day 1, alizarin injections (25 mg/kg, i.v.) were administered on
day 7 and day 8, and rabbits were euthanized on day 10 (Figure 2.2A). Following microCT
scans, a 10 mm segment of each ulna was cut from the ulna diaphysis beginning at 35% of the
ulna length from the olecranon, again selecting an area of cortical bone outside of the fractured
region. Ulnar samples were then embedded in methyl methacrylate and 100 μm sections were cut
from the ulna mid-diaphysis using a saw-microtome (Leica SP1600). Sections were polished
using sandpaper to a final thickness of 30-40 μm and imaged as a series of 20X magnification
images to capture the entire ulna (Olympus IX51). Individual images were then compiled into a
single merged image (Microsoft Image Composite Editor) and analyzed (Bioquant 2016) for
bone formation parameters [71].
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2.3.6 Experiment 2: Sub-Fracture Fatigue Loading and Fuchsin Staining
Microdamage produced by sub-fracture fatigue loading was assessed (Figure 2.2 B).
Forelimbs were cyclically loaded at 2 Hz to 130 N, which was 75% of the average ultimate force
from experiment 1. We wanted to select levels of fatigue which were advanced enough to create
microdamage, but before the threshold for macrocrack, or stress fracture, formation (event 1,
Figure 2.4 A) [70]. Therefore, we selected two stopping displacements to test levels of fatigue
for microdamage formation. The average displacement to fracture for rabbits was 3.24 mm
(Figure 3C) and the average displacement to “event 1” was 1.57 mm. Therefore, displacements
of 25% (0.81 mm) and 40% (1.30 mm) of the displacement to fracture were chosen (Figure 2.2
B). The 25% displacement was termed “low fatigue” and the 40% displacement was termed
“moderate fatigue”.
Eleven OVX rabbits (n = 22 forelimbs) underwent non-survival, bilateral loading and
each forelimb was randomly assigned to the non-loaded, low-fatigue, or moderate-fatigue group
(n = 6-8/group; Figure 2.2 B). Following sacrifice, forelimbs were processed for en bloc fuchsin
staining on 25 mm segments of ulna cut to center around the average fracture location from
experiment 1 (59% of normalized length). Ulnar samples were infiltrated with fuchsin through
sequential 24-hour baths in 1% fuchsin solutions in 80% ethanol, 90% ethanol, and 100%
ethanol [72]. Stained bones were then embedded in plastic and histology slices were cut and
imaged (as above, Section 2.3.5). Diffuse damage and linear microcracks, two distinct kinds of
microdamage, were quantified for one section from each ulna.
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2.3.7 Experiment 3: Survival Fatigue Loading
Twelve OVX rabbits were used for survival, unilateral fatigue loading to a moderate
fatigue level (1.30 mm). Right forelimbs were loaded and left forelimbs were used as non-loaded
controls. Rabbits were randomly assigned to either a 3 or 6 week survival group (Figure 2.2 C).
For the 3 week group, calcein was administered on consecutive days beginning on day 4 and day
18 and alizarin was administered on consecutive days beginning on day 11. Rabbits were
sacrificed on day 21 after loading and bones were processed for plastic (n = 3) or paraffin (n = 3)
embedded histology. For the 6 week group, calcein was administered on consecutive days
beginning on day 25 and day 40 and alizarin was administered on consecutive days starting on
day 32. Rabbits were sacrificed on day 42 after loading and forelimbs were processed for plastic
(n = 3) or paraffin (n = 3) embedded histology. Plastic embedded histology was processed for
dynamic histomorphometry to observe loading induced bone formation and microdamage
induced intracortical remodeling. Ulnas for paraffin histology were decalcified by 14 days of
14% EDTA treatment prior to embedding. Thin sections were stained with hematoxylin and
eosin and were imaged using a Nanozoomer slide scanner (Hamamatsu) at 20X magnification.

2.3.8 Statistics
Data is represented throughout as mean with error bars of one standard deviation. All
statistical tests were performed using Prism software (GraphPad Prism 8.1.1). Due to non-normal
distributions in data, all comparisons between sham and OVX were performed with unpaired
non-parametric Mann-Whitney tests. In order to compare between non-loaded, low fatigue, and
moderate fatigue groups for levels of microdamage Kruskal-Wallis tests with multiple

24

comparisons were performed. Bone remodeling parameters in survival fatigue model were
analyzed with 2-way repeated measure ANOVA in order to account for paired nature of results
and multiple time points. Significance was considered to be p < 0.05 for all tests.

2.4 Results
2.4.1 The biomechanics of the forelimb are unchanged by OVX
Forelimbs from sham and OVX rabbits did not have significant differences in
biomechanics under either monotonic or fatigue loading (Figures 2.3 & 2.4). Ultimate force and
stiffness were not different between OVX and Sham (Figure 2.3 B & C). Work to fracture had a
slight, but non-significant increase following OVX (p = 0.184; Figure 2.3 D). Similarly, there
were no differences between groups with cyclic loading in displacement to event 1 (Figure 2.4
B), displacement to fracture (Figure 2.4 C), and normalized fracture stiffness (Figure 2.4 D). The
average number of cycles to fracture was 9,405 ± 8,385 cycles for sham and 8,243 ± 8,245
cycles for OVX. The average location of fracture was at 59% of the normalized length of the
ulna.
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2.4.2 No changes in cortical or cancellous bone are observed by microCT
following OVX

MicroCT revealed no difference between OVX and sham rabbits in cortical bone
parameters such as bone area, total area, medullary area, cortical thickness or tissue mineral
density (Figure 2.5 A). Likewise, no differences were detected in cancellous bone parameters
such as bone volume fraction, trabecular thickness, trabecular number, trabecular separation, and
volumetric bone mineral density (Figure 2.5 B).
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Figure 2.5: Experiment 1 - MicroCT evaluation of the cortical and cancellous compartments of the ulna.
(A) A 2.2 mm segment of the ulnar diaphysis was analyzed to obtain properties of the cortical bone. Parameters
including bone area, total area, medullary area, cortical thickness (Ct.Th), and tissue mineral density (TMD) did
not differ between groups. (B) A 2.2 mm segment of the proximal ulna was analyzed to obtain cancellous bone
properties. Parameters such as bone volume/total volume (BV/TV), trabecular thickness (Tb.Th), trabecular
number (Tb.N), trabecular separation (Tb.Sp), and volumetric bone mineral density (vBMD) did not differ between
groups. n = 8-10/group.
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2.4.3 Increased remodeling was observed in the ulna following OVX
Using dynamic histomorphometry we observed more calcein and alizarin labeling in the
ulna of OVX rabbits than sham rabbits (Figure 2.6 A & B). There were significant increases in
labeled osteons (Figure 2.6 C), and periosteal mineralizing surface, mineral apposition rate, and
bone formation rate (Figure 2.6 D-F). No difference was seen in endocortical parameters (Table
2.1).

Table 2.1: Dynamic histomorphometry outcomes for baseline skeleton.
Intracortical
Lb.On

Sham (n=10)
OVX (n=8)

Periosteal
MS/BS

MAR

Endocortical
MS/BS

BFR

MAR

BFR

(#/section)

(%)

(μm/d)

(μm /μm /d)

(%)

(μm/d)

(μm3/μm2/d)

0.50 ± 0.71
4.42 ± 5.71
p = 0.006

5.87 ± 3.51
27.57 ± 17.79
p = 0.019

0.31 ± 0.99
1.60 ± 0.87
p = 0.001

0.03 ± 0.08
0.54 ± 0.47
p = 0.001

21.12 ± 13.85
21.95 ± 7.90
p = 0.999

1.40 ± 1.37
2.22 ± 0.94
p = 0.156

0.38 ± 0.45
0.49 ± 0.23
p = 0.410

3

Values are displayed as mean ± standard deviation
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Figure 2.6: Experiment 1 - Dynamic histomorphometry of baseline remodeling in the rabbit ulna. Calcein and alizarin
red fluorochromes were used to visualize locations of mineralization. An ulnar transverse section of (A) a sham operated
animal and (B) an OVX animal show typical pattern of fluorochrome labels. (C) The amount of labeled osteons (L.On)
increases for the OVX group. (D) The amount of periosteal (Ps.) mineralizing surface (MS/BS), mineral apposition rate
(MAR) and bone formation rate (BFR) were also increased in the OVX group as compared to sham. (E) No difference was
observed for endocortial parameters between groups (Table 2.1). Asterisk (*) denotes p < 0.05. n = 8-10/group.
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2.4.4 Reliable creation of microdamage with sub-fracture fatigue loading was
not achieved

The average number of loading cycles was 317 ± 434 cycles for low fatigue and 2,168 ±
2,542 cycles for moderate fatigue. En bloc fuchsin staining was used to visualize microdamage
following no loading, low, or moderate fatigue (Figure 2.2 B). Fuchsin staining revealed
microdamage was present in each group (Figure 2.7 A). However, no increase in diffuse damage
(Figure 2.7 B) or linear microcracks (Figure 2.7 C) was observed with either low or moderate
fatigue loading compared to control. Furthermore, stress fractures developed in two of the twelve
loaded limbs, one each in the low and moderate fatigue group (Figure 2.8).
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Figure 2.7: Experiment 2 - Analysis of microdamage after sub-fracture fatigue loading. Rabbit forelimbs
were loaded as part of Experiment 2 design (Figure 1B). (A) Representative images of each group following
fuchsin staining with insert showing magnified view of peak compressive region of the ulnar cortex. (B) Diffuse
damage normalized to total volume (Dfdx/TV) and (C) linear microcracks normalized to total volume (Mc/TV)
were not different between groups. n = 6-7/group.
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Figure 2.8: Experiment 2 - Macrocrack formation following low and moderate fatigue. Two stress fractures developed
in ulna during fatigue loading. A stress fracture was observed by fuchsin staining in each of the low and moderate fatigue
groups. The goal of this fatigue regime was to stop prior to macrodamage formation, which was not achieved in these two
specimens.
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2.4.5 Fatigue loading resulted in increased intracortical remodeling and
periosteal bone formation
The average number of cycles for the survival fatigue loading was 1,509 ± 1,364 cycles.
Following survival fatigue loading, an increased amount of fluorochrome labeling can be
observed at 3 weeks and 6 weeks after loading when compared to non-loaded limbs (Figure 2.9
A). Repeated measures 2-way ANOVA showed a significant fatigue loading effect on
intracortical remodeling (p = 0.036), periosteal mineralizing surface (p = 0.031), mineral
apposition rate (p = 0.044) and bone formation rate (p = 0.014), and a significant time effect on
periosteal bone formation rate (p = 0.042) (Figure 2.9 B-E). Multiple comparisons were then
used to test significance between individual groups. Fatigue loading did not significantly
increase intracortical remodeling in the first 3 weeks, but in the 6 week group there was an
increase in labeled osteons (Figure 2.9 B). Fatigue loading also initiated a robust formation of
periosteal lamellar bone as shown by increases in mineralizing surface (Figure 2.9 C), mineral
apposition rate (Figure 2.9 D), and bone formation rate (Figure 2.9 E). The increased bone
formation was strongest in the 3-week group but persisted in the 6-week group. Analysis of H&E
stained histology did not reveal any basic multicellular units or areas of matrix remodeling
within the cortical bone of loaded ulna (Figure 2.10).
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Figure 2.9: Experiment 3 - Response to survival sub-fracture fatigue loading. Rabbit forelimbs were loaded
as part of Experiment 3 (Figure 1C). (A) Representative images of calcein and alizarin staining in ulna cross section
for non-loaded, 3 week, and 6 week groups with insert showing magnified view of periosteum near the site of peak
strain. (B) Labeled osteons (L.On) were significantly increased 6 weeks following loading. (C) Periosteal
mineralizing surface (Ps.MS/BS) had non-significant increases at both 3 weeks and 6 weeks. (D) Periosteal mineral
apposition rate (Ps.MAR) was significantly higher in the 3 week group, but not the 6 week group. (E) Periosteal
bone formation rate (Ps.BRF/BS) was significantly higher in the 3 week group and trending higher in the 6 week
group. Asterisk (*) denotes p < 0.05. n = 3/group.
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Figure 2.10: Experiment 3 - Histology of survival fatigue loaded ulna. Histology of ulna from survival loading
rabbits were stained with hematoxylin and eosin. A full cross section of a non-loaded control ulna is shown (A),
and regions of peak mechanical strain (B) and large amounts of osteons (C) are shown at higher magnification.
Similar images are shown for the 3 week group (D-F) and the 6 week group (G-I). No evidence of increased
intracortical remodeling is seen in the loaded limbs. Furthermore, the areas we expected to be most impacted by
loading (B, E, & H) did not feature many osteons, while regions of the ulna not expected to be targeted by this
loading model featured many osteons (C, F, & I). Scale bars were 500 μm in A, D, & G, and 100 μm in B,C, E, F,
H, & I. n = 3/group.
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2.5 Discussion
Herein, the rabbit forelimb fatigue model was modified to create sub-fracture damage in
osteoporotic rabbits. The goals of this work were to adapt the model for use in OVX rabbits, to
define loading parameters to achieve consistent microdamage creation, and to visualize an
intracortical repair process following fatigue.
OVX has been used to induce osteoporosis in rabbits in several studies, and is associated
with reduced BMD in the femur and lumbar spine [66–68]. However, the impact of OVX on the
ulna, the bone of interest in this fatigue model, has not been reported. MicroCT showed no
difference in the cortical bone parameters of the ulna (Figure 2.5). Similarly, we did not find
significant differences in cancellous parameters between OVX and sham groups. The trends we
observe are consistent with previous reports of the rabbit OVX model. Pennypacker et al. [66]
reported a 9.8 % to 12.8% reduction in BMD of the lumbar spine following OVX, whereas we
observe a non-significant difference of 12% in the cancellous compartment of the ulna. The same
study reported that after OVX, cortical bone parameters of the femur diaphysis such as TMD and
cortical area remained unchanged, consistent with our data of the ulna diaphysis. Thus, the
changes we observed in the microCT data of OVX rabbits are marginal, but are comparable to
previous reports. Post-hoc power analysis reveals that our analysis was underpowered to detect
small effects, and that sample sizes would need to be more than doubled to n = 26 to adequately
detect differences of 12%.
We used dynamic histomorphometry to observe baseline remodeling in OVX ulna (Figure
2.6). Compared to the sham group, OVX ulnas had increased levels of osteonal remodeling and
periosteal labeling, both of which are established features of OVX in non-rodent models [66,73].
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This result was consistent with Pennypacker et al. [66], who reported intracortical remodeling
increasing from 0 to 4.5 labeled osteons per section in rabbit OVX femur, while our data show
an increase from 0.5 to 4.4 labeled osteons per section in OVX ulna . Furthermore, Pennypacker
and colleagues reported a 5.1 fold increase in periosteal mineralizing surface in OVX femur,
which corresponds to our 4.7 fold increase in OVX ulna. We conclude that OVX successfully
induced an osteoporotic-like state within the skeleton of these rabbits, albeit with limited effects
on bone mass.
We achieved the goal of adapting the forelimb fatigue model for use with OVX rabbits,
mainly because OVX had little effect on loading behavior. Comparison of the biomechanics of
OVX rabbits to sham-operated animals shows similar behavior, which is consistent with
microCT revealing no difference between OVX and sham cortical bone. Parameters such as
ultimate force and fatigue displacement to fracture showed equal variability in sham and OVX,
allowing for the selection of a loading force and stopping displacement parameters for subfailure loading that were applied to all OVX animals used in subsequent experiments.
We sought to use sub-fracture fatigue loading to induce microdamage accumulation in the
cortical bone of the ulna. To do this, stopping displacements were selected to target enough
fatigue for microdamage creation, but stop short of macrocrack initiation (Figure 2.2 B) [70].
However, no differences in microdamage burden were identified by fuchsin staining (Figure 6).
This was in contrast to reports that have used similar loading regimes to successfully induce
microdamage accumulation in rat ulna [59,60,69]. Furthermore, two fatigue loaded limbs
developed inadvertent macrocracks (Figure 2.8). This represents a challenge of targeting subfracture fatigue in rabbit forelimbs, which display large variability in the displacement to event 1
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(Figure 2.4 B). Thus, our second goal of creating consistent microdamage was not achieved with
these loading parameters.
Survival loading was used to visualize the repair response of OVX rabbits to sub-fracture
fatigue. We observed an increase in intracortical labeling at 6 weeks, but not at 3 weeks (Figure
2.9 B). This suggests that the fatigue regime generated sufficient stimulus to induce an
intracortical remodeling response, even in the absence of observable increases in microdamage
burden (Figure 2.7). Despite the presence of intracortical labeling in dynamic histomorphometry,
we did not observe signs of remodeling in H&E stained histology sections (Figure 2.10).
Therefore, our third goal of observing an intracortical repair response to loading was only
partially accomplished.
Periosteal bone formation was increased at both 3 and 6 weeks post-fatigue. This indicates
induction of a remarkably persistent and robust lamellar loading response from a single bout of
loading, and could be an interesting avenue of future study. Therefore, beyond its usefulness in
sub-fracture fatigue, this model may be suitable for the study of loading-induced bone formation
similar to the approach developed by Baumann and colleagues [74].
Several caveats for this work should be noted. Firstly, the non-survival sub-fracture fatigue
characterization experiment (#2) and the survival experiment (#3) were performed concurrently.
This hampered our ability to completely explore the range of fatigue levels before moving into
survival experiments, and thus we did not obtain the increased microdamage burden we
anticipated. Any future studies would need to identify a fatigue protocol which can more reliably
generate microdamage. In our experience with cyclic loading of the rabbit forelimb, there is a
very narrow window between non-damaging loading that stimulates lamellar bone formation,
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and damaging loading that creates macrodamage/stress fracture. Secondly, it should be noted that
these experiments, especially the survival loading, have limited sample size due the expense and
time of working with rabbits. Finally, our goal was to create a model of fatigue loading in
osteonal bone. But we observed that the areas of the rabbit ulna most affected by axial
compression do not contain many osteons (Figure 2.10) [70].

2.6 Conclusions
We set out to modify the rabbit forelimb stress fracture model to produce sub-fracture
microdamage accumulation and stimulate intracortical repair in osteoporotic and osteonal bone.
We succeeded in adapting the use of this model to OVX animals and were also able to observe
increased intracortical remodeling following loading. However, we were ultimately unsuccessful
in producing reliable levels of sub-fracture microdamage, and thus the utility of this model to
study interactions between microdamage accrual and repair is not yet established. In our
experience with cyclic loading of the rabbit forelimb, there is a very narrow window between
non-damaging loading that stimulates lamellar bone formation, and damaging loading that
creates macrodamage/stress fracture.
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Chapter 3: Transcriptional Profiling of
Intramembranous and Endochondral
Ossification after Fracture in Mice
3.1 Abstract:
Bone fracture repair represents an important clinical challenge with nearly 1 million nonunion fractures occurring annually in the U.S. Gene expression differs between non-union and
healthy repair, suggesting there is a pattern of gene expression that is indicative of optimal
repair. Despite this, the gene expression profile of fracture repair remains incompletely
understood. In this work, we used RNA-seq of two well-established murine fracture models to
describe gene expression of intramembranous and endochondral bone formation. We used top
differentially expressed genes, enriched gene ontology terms and pathways, callus cellular
phenotyping, and histology to describe and contrast these bone formation processes across time.
Intramembranous repair, as modeled by ulnar stress fracture, and endochondral repair, as
modeled by femur full fracture, exhibited vastly different transcriptional profiles throughout
repair. Stress fracture healing had enriched differentially expressed genes associated with bone
repair and osteoblasts, highlighting the strong osteogenic repair process of this model.
Interestingly, the PI3K-Akt signaling pathway was one of only a few pathways uniquely
enriched in stress fracture repair. Full fracture repair involved a higher level of inflammatory and
immune cell related genes than did stress fracture repair. Full fracture repair also differed from
stress fracture in a robust downregulation of ion channel genes following injury, the role of

40

which in fracture repair is unclear. This study offers a broad description of gene expression in
intramembranous and endochondral ossification across several time points throughout repair and
suggests several potentially intriguing genes, pathways, and cells whose role in fracture repair
requires further study.

3.2 Introduction
Skeletal fractures are an important clinical problem. About 16 million fractures occur
annually in the U.S. – roughly one every two seconds [37]. Over the next decade, the national
economic burden of fractures is estimated at $25 billion. Bones have a strong capacity for selfrepair and, with proper intervention, most fractures will heal without major complications.
Importantly though, about 5 to 10% of fracture patients will not heal adequately – suffering from
either delayed- or non-union healing [38]. Delayed and non-union fractures are painful, costly,
and require additional surgical interventions. Although many comorbidities are associated with
nonunion, their molecular pathogenesis is unclear, thus representing an important target for
research [15].
Bones fracture in several ways, depending on the mechanical cause of injury. Two broad
categories, stress fractures and full fractures, are the focus of this work. Stress fractures are
defined by a crack which is partially propagated, non-displaced, and unicortical [75,76]. Stress
fractures are caused by repetitive overuse that leads to bone fatigue damage [77,78].
Alternatively, full fractures occur by complete propagation of one or more cracks across the bone
cortices, resulting in a displaced fracture [79]. Full fractures are typically caused by a sudden
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overload of the bone, as experienced in trauma. These different injuries trigger distinct repair
cascades.
Stress fractures heal by intramembranous ossification, the direct formation of a bone
callus without a cartilaginous intermediary [6]. Full fracture heals primarily through
endochondral ossification, which features an intermediary cartilaginous callus [5] that is then
replaced by bone, with some intramembranous ossification occurring at the stable margins of the
fracture callus. The stability of the injury site and the displacement caused by the injury
determine which bone formation mechanism occurs [7]. Intramembranous ossification is favored
by stable injuries with little displacement and endochondral ossification is preferential when
injuries are unstable and displaced. The distinct processes for intramembranous and
endochondral bone formation are well documented – and transcriptomic analysis of each has
individually been reported. Several studies have used microarray technology to assay gene
expression in models of endochondral ossification in mouse [80–82], rats [83], and humans [84],
and additional work has been performed using RNA-seq in mouse [85]. These works describe
the complex transcriptional response following full fracture, which involves, inflammatory,
angiogenic, chondrogenic, and osteogenic processes. There are few reports of gene expression in
intramembranous ossification, with one report using microarray to study stress fracture healing
in rat [29], which described strong expression of inflammatory, angiogenic, and osteogenic
genes.
While these studies were illuminating, a more direct comparison of the gene expression
profiles of intramembranous and endochondral ossification might provide additional insight. For
example, while both processes involve inflammation, the relative scale of the inflammatory
response is likely to be less after stress fracture than full fracture. Furthermore, sampling from
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several time points following injury will provide information on how gene transcription changes
throughout repair. A comparison of intramembranous and endochondral ossification spanning
several time points across the repair window, using contemporary RNA-seq analysis, would
address these knowledge gaps and shed light on similarities and differences between these two
processes. Studies have shown that transcriptional differences exist between successful and nonunion bone fracture repair [84] as well as young mice and slowly healing geriatric mice [80].
However, gene expression of poor healing is difficult to utilize if normal healing is incompletely
understood. Therefore, a more comprehensive understanding of the transcription of endochondral
and intramembranous ossification could better inform the treatment of delayed- and non-union
fractures.
The goal of this work is to provide a detailed description of the temporal transcriptional
response occurring in the fracture repair processes of intramembranous and endochondral
ossification. We used two well-established murine fracture models and RNA sequencing to assay
gene expression at five time points following stress fracture and full fracture. We hypothesized
that endochondral repair would feature a greater number of differentially expressed genes than
intramembranous repair, and that many of the genes unique to full fracture would be related to
inflammation and chondrogenesis. Furthermore, we hypothesized that this analysis would reveal
novel transcriptional differences between these two healing modalities.
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3.3 Materials and Methods
3.3.1 Mice

Within an IACUC approved protocol, a total of 97 female C57BL/6J wild-type mice
(Jackson Labs) were obtained at 9 weeks old and were aged to 12 weeks old for experimental
use. We chose a single sex to limit the scope of the study, and selected females because women
have higher rates of fracture [86,87]. Mice were kept on a 12:12 light/dark cycle and were fed
chow ad libitum. A group of 47 mice were subjected to unilateral ulnar stress fracture and were
randomly assigned to post-fracture time points of 4 hours, 1, 3, 5, or 7 days for either RNA
extraction (N = 25) or histological processing (N = 22) (Figure 3.1 A). Additionally, a set of 50
mice were subjected to unilateral full femur fracture and were randomly assigned to post-fracture
time points of 4 hours, 1, 3, 7, or 14 days for either RNA extraction (N = 35) or histology
processing (N = 15) (Figure 3.1 A). We selected time points based on historical data to survey
the various important phases of the early fracture repair response (i.e. inflammation,
angiogenesis, chondrogenesis, and early osteogenesis). Differences in the later time points reflect
the relatively longer time to peak osteogenesis in full versus stress fracture repair. All animals
were healthy at time of injury and body weight was consistent between groups (mean body
weight = 20.8 ± 1.3 g). Mice were euthanized by CO2 asphyxia at the assigned post-injury time
point.
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Figure 3.1: Experimental overview of fracture models, time points, and RNA-seq pipeline. (A) 97 female
C57BL/6J mice were injured with stress or full fracture, sacrificed at 4 hours, 1, 3, 5, 7, or 14 days post-injury,
and processed for RNA-seq or histology. (B) RNA-seq analysis began with RNA extraction from pulverized bone
tissue. RNA was sequenced and reads were mapped to mm10 genome. Differential expression analysis was
performed to create lists of differentially expressed genes (DEGs) for each time point. Comparison to previously
generated qPCR data of stress and full fracture callus was used to validate RNA-seq data. Callus component
analysis using transcriptional profiling of callus cells was performed at each time point. Pathway analysis and GO
annotation were performed on the DEG lists of each time point.

3.3.2 Stress Fracture

We used ulnar stress fractures to study intramembranous ossification. The murine
forelimb fatigue model used to create stress fractures was described in detail in previous reports
[88,89]. Briefly, mice were anesthetized with 1-3% isoflurane and the right forelimb was
positioned between two fixtures on a material testing machine (Instron Dynamite). Calibration
mice were loaded with a monotonic displacement ramp to determine ultimate force of the
forelimb and with cyclic compression to determine fracture displacement. Experimental mice
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were loaded using force-controlled cyclic compression to a peak of 3.0 N (75% of mean ultimate
force, 2 Hz) applied to the forelimb until an increase in total displacement of 0.5 mm (50% of
mean fracture displacement) was achieved. The average number of cycles applied was 5,383
(range: 105 – 18,627). Time zero for the stress fracture was considered to be the time of the final
loading cycle, as the crack growth mostly occurs in the last few cycles of loading. The left ulna
served as a non-injured contralateral control. Following loading, the mouse was administered
buprenorphine (0.1 mg/kg, s.c.) for analgesia and returned to the cage with unrestricted activity
until time of sacrifice. Mice returned to subjectively normal activity levels within minutes of
being returned to their cage.

3.3.3 Full Fracture

We used femur full fractures to study endochondral ossification. The femur fracture
procedure was described in detail in previous reports [44]. In brief, mice were anesthetized with
1-3% isoflurane, and slow release buprenorphine (1 mg/kg, s.c.) was administered for pain
management. The right femur was exposed through a small incision and notched with a scalpel
to pre-dispose the mid-diaphysis to fracture. The right hind limb was then secured in a threepoint bending fixture on a material testing machine (Instron Dynamite) and a monotonic
displacement ramp (30 mm/s) was applied to produce a transverse fracture in the mid-diaphysis
of the femur. A 24G pin was inserted into the intramedullary space to provide mechanical
stability and the incision was closed. Fracture location and pin placement were confirmed by Xray radiography (Faxitron UltraFocus). Mice were then returned to unrestricted cage activity and
reached relatively normal activity levels within a few hours of the procedure. Generation of
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fractures had good reproducibility with consistent tissue damage, actuator displacement, stability
of the fracture, and lack of comminution. The left femur served as a non-fractured contralateral
control. Radiographs were again taken at time of sacrifice to reconfirm intramedullary pin
placement. Mice were excluded from analysis if fracture occurred outside the mid-diaphysis (n =
5) or if the stabilization pin had slipped from the intramedullary space by time of sacrifice (n =
1).

3.3.4 RNA extraction and sequencing

For stress fracture, a 5 mm section of the ulna was removed surrounding the injury site.
Soft tissue was removed, the sample was flash frozen in liquid nitrogen, and stored at -80 °C
until RNA extraction. The left ulna was similarly processed to serve as a control. For full
fracture, a 7 mm section of the femur was removed surrounding the injury site. Soft tissue was
removed and bone marrow was spun out using a centrifuge. The sample was flash frozen in
liquid nitrogen and stored at -80 °C until RNA extraction. The left femur was similarly processed
to serve as a control.
Frozen bone samples were pulverized (Braun Mikrodismembrator), dissolved into TRIzol
(Invitrogen), and stored at -80 °C. Later, the TRIzol-sample solution was thawed and processed
using an RNA clean-up and concentration kit (Norgen Biotek) (Figure 1B). RNA concentration
was measured (Thermo Scientific Nanodrop ONE) and quality was evaluated (Agilent
Technologies Bioanalyzer 2100). Only samples with RINs > 6.5, representing acceptable quality,
were used in sequencing; samples not meeting this criterion were excluded (n = 4).
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A total of 70 samples were subjected to RNA-seq (Figure 3.1 B). For each fracture type,
there were 25 fracture samples (n = 5/time point) and 10 control samples (n = 2/time point).
Total RNA was depleted of rRNA (Illumina, Ribo-Zero rRNA Removal Kit) and RNA-seq
(Illumina HiSeq 3000) was performed at 1x50 bp on 1 μg of RNA by the Washington University
Genome Technology Access Center. The RNA-seq reads were aligned to the mm10 mouse
genome (STAR version 2.4.2a). Gene counts were derived from the number of uniquely aligned
unambiguous reads (Subread:featureCount, version 1.4.6) and annotated (GENCODE v9). Only
non-redundant uniquely aligned reads were used to estimate the expression level of genes. All
gene-level transcript counts were then normalized for library size (R/Bioconductor DEseq2).
Lowly expressed genes (CPM<1) in all the samples at any time points were filtered out, and
resulted in 17,240 genes for down-stream analysis. To check for outlier samples a correlation
analysis was performed (cutoff of r > 0.85). In stress fracture, three samples (one each from
control, day 1, and day 7) were flagged as outliers and removed from further analysis. In full
fracture, all samples passed this inspection. Differential expression analysis was performed
separately for each injury mode and each time point as a comparison of injured samples vs.
pooled control samples, with a threshold for differentially expressed genes (DEGs) set as foldchange (FC, Injured/Control) > 2 and Benjamini-Hochberg adjusted p-value < 0.05. Additional
characterization was performed by a principle component analysis on stress fracture and full
fracture samples separately. For each sample, the reads per kilobase of transcript per million
mapped reads (RPKM) values for all 17,240 genes in the data set were used as inputs.
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3.3.5 Validation of RNA-Seq data

In order to validate RNA-seq gene expression, we made comparisons to qPCR data
previously generated in our lab using similar fracture models on control mice of similar age, size,
and background. Fold change (FC) values for full fracture at days 7 and 14 post-injury, and
stress fracture at days 1, 3, and 7 post-injury were correlated to FC values previously reported for
49 transcripts resulting in 94 comparisons as some transcripts were in multiple time points (Table
3.1) [44,88,89]. Additionally, we performed qPCR for select genes on remaining RNA from full
fracture samples. Collagen Type 1a1 (Col1a1), Aggrecan (Acan), and Potassium Voltage-Gated
Channel Subfamily J Member 5 (Kcnj5) were chosen in order to sample genes from various
processes with differing expression profiles. cDNA was produced (Biorad iScript) from 500 ng
of RNA for all full fracture samples from days 1, 3, 7 and 14 and corresponding contralateral
femurs. qRT-PCR was performed (Applied Biosystems StepOnePlus) using primers (IDT
PrimeTime) for Col1a1 (Mm.PT.58.7562513), Acan (Mm.PT.58.23585796), and Kcnj5
(Mm.PT.58.6016350) and reference genes TATA Binding Protein (Tbp, Mm.PT.58.42394711)
and Importin 8 (Ipo8, Mm.PT.39a.22214844). Expression was normalized to reference genes and
fold changes were determined by ΔΔCT method comparing to contralateral limb.
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Table 3.1: Genes used in comparison of qPCR data to RNAseq data.
Gene ID
Gli1
Ptch1
Ihh
Dhh
Ibsp
Bglap
Sp7
Col1a1
Acan
Sox9
Col2a1
Fgf2
Tek
Vegfa
Hmox1
Nos2
Ang
Ang2
Tie1
Ptn
Acan
Bmp2
Bmp3
Bmp4
Bmp7
Ibsp
Chrd
Col1a1
Col2a1
Grem1
Nog
Sp7
Sox9
Vegfa
Bmp2
Ibsp
Sp7
Vegfa
Hif1a
Col1a1
Col2a1
Fgfr1
Fgfr2
Fgfr3
Fgf1
Fgf2
Fgf9
Fgf16
Fgf18

Injury
Full Fracture
Full Fracture
Full Fracture
Full Fracture
Full Fracture
Full Fracture
Full Fracture
Full Fracture
Full Fracture
Full Fracture
Full Fracture
Full Fracture
Full Fracture
Full Fracture
Full Fracture
Full Fracture
Full Fracture
Full Fracture
Full Fracture
Full Fracture
Full Fracture
Full Fracture
Full Fracture
Full Fracture
Full Fracture
Full Fracture
Full Fracture
Full Fracture
Full Fracture
Full Fracture
Full Fracture
Full Fracture
Full Fracture
Full Fracture
Stress Fracture
Stress Fracture
Stress Fracture
Stress Fracture
Stress Fracture
Stress Fracture
Stress Fracture
Stress Fracture
Stress Fracture
Stress Fracture
Stress Fracture
Stress Fracture
Stress Fracture
Stress Fracture
Stress Fracture

Time point
D7, D14
D7, D14
D7, D14
D7, D14
D7, D14
D7, D14
D7, D14
D7, D14
D7, D14
D7, D14
D7, D14
D7, D14
D7, D14
D7, D14
D7, D14
D7, D14
D7, D14
D7, D14
D7, D14
D7, D14
D7
D7
D7
D7
D7
D7
D7
D7
D7
D7
D7
D7
D7
D7
D1, D3, D7
D1, D3, D7
D1, D3, D7
D1, D3, D7
D1, D3, D7
D1, D3, D7
D1, D3, D7
D1, D3, D7
D1, D3, D7
D1, D3, D7
D1, D3, D7
D1, D3, D7
D1, D3, D7
D1, D3, D7
D1, D3, D7
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Source
Liu et al.
Liu et al.
Liu et al.
Liu et al.
Liu et al.
Liu et al.
Liu et al.
Liu et al.
Liu et al.
Liu et al.
Liu et al.
Liu et al.
Liu et al.
Liu et al.
Liu et al.
Liu et al.
Liu et al.
Liu et al.
Liu et al.
Liu et al.
McBride et al.
McBride et al.
McBride et al.
McBride et al.
McBride et al.
McBride et al.
McBride et al.
McBride et al.
McBride et al.
McBride et al.
McBride et al.
McBride et al.
McBride et al.
McBride et al.
Martinez et al.
Martinez et al.
Martinez et al.
Martinez et al.
Martinez et al.
Martinez et al.
Martinez et al.
Martinez et al.
Martinez et al.
Martinez et al.
Martinez et al.
Martinez et al.
Martinez et al.
Martinez et al.
Martinez et al.

3.3.6 Gene Ontology and Pathway Analyses

For gene ontology analysis, each of the ten DEG lists (2 injury types x 5 time points) was
input into the Database for Annotation, Visualization and Integrated Discovery (DAVID) system
as a gene list [90,91]. Annotations were limited to Mus musculus. Biological process gene
ontology (GO) terms and enriched pathways from the Kyoto Encyclopedia of Genes and
Genomes (KEGG) database were obtained for each list and filtered to remove non-significant
terms (Bonferroni p < 0.05).

3.3.7 Callus Component Phenotyping

To identify various populations of cells in the callus following stress or full fracture, we
followed an approach described by Angelova et al. in the immunophenotyping of tumor biopsies
[92]. Briefly, they used RNA-seq of bulk tumor biopsies and compared the gene expression
against curated lists comprised of genes specific to certain immune cell types. By comparing the
gene expression of curated lists, a census of immune cells residing in the tumor can be inferred.
In a similar manner, we used RNA-seq of fracture callus tissue, in combination with curated
gene lists, to infer the cellular populations present at various stages of stress and full fracture
repair. Gene lists were compiled from literature reviews for neutrophils, macrophages,
monocytes, T cells, and B cells [92]; as well as osteoblasts [93,94], osteoclasts [95–99],
endothelial cells [100,101], and chondrocytes [102–105] (Table 3.2) . We then examined the fold
change of these genes across time following stress and full fracture as an estimate of the
abundance of each cell type within the callus.
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Table 3.2: Genes used in callus component phenotyping
Cell Type
Neutrophil
Macrophage
Monocyte

T Cells

B Cells

Gene List
Abtb1, Ampd2, Camp, Fpr1, Fpr2, Maea, Prok2, Sec14l1, Slc25A37,
Tnsfs14, Treml4, Xpo6
Aif1, Cd163, Cd300lb, Cnr1, Cnr2, Cpm, Csf3r, Eng, Igf1, Il34, L1cam,
Lilra5, Lrp1, Ms4a7, Trem1, Treml1
Actr3, Anxa5, Arpc2, Atp6v1b2, Basp1, Cd300lf, Dazap2, Eif4a1, Eif4g2,
Emp3, Gabarap, Hif1a, Litaf, Ncoa4, Olr1, Rab1a, Rhoa, Sat1, Sdcbp, Srgn,
Tek, Tmbim6, Ube2d3

References
Angelova et al.

Batf, Btla, Ccl11, Ccl3, Ccl5, Ccl7, Ccr1, Ccr3, Cd247, Cd28, Cd3d, Cd3e,
Cd3g, Cd69, Cd8a, Cxcr4, Cxcr5, Cxcr6, Flt3, Fosl1, Grap2, Hrh2, Il10,
Il12rb1, Il12rb2, Il18r1, Il18rap, Il1b, Il21r, Il27, Il2ra, Il6, Il7, Ilrf4, Irf8,
Itgal, Itk, Jak2, Jak3, Lair1, Lat, Lax1, Lck, Lcp2, Ms4a4a, Nfatc1, Nfkb2,
P2ry14, Pik3cd, Pou2f2, Prf1, Runx3, Spi1, Stat1, Stat4, Tnf, Ubash3b,
Zap70
Akna, Arhgap25, Cd180, Cd2, Cd276, Cd37, Cd38, Clec9a, Fam65b,

Angelova et al.

Angelova et al.
Angelova et al.

Angelova et al.

Gimap4, Map4k1, Pax5, Traf3ip3
Osteoblasts

Sp7, Bglap, Col1a1, Col1a2, Alpl, Sparc, Ibsp, Dmp1, Maged1, Pard6g,
Kdelr3, Rcn3, Col5a1, Fkbp10, Tmem119, Gja1

Calabrese et al., Rodan
& Noda

Osteoclasts

Ocstamp, Ctsk, Calcr, Spi1, Tnfrsf11a, Csf1, Src, Mmp9, Oscar, Tnfsf11,
Efna2, Tyrobp

Barrow et al., Irie et al.,
Jiang et al., Yang et al.,
Zaidi et al.

Endothelial
Cells

Kdr, Cdh5, Erg, Tek, Pecam1, Acta2, Cspg4, Ptprc, Vegfa, Angpt2, Hif1a,
Flt1

Rivera et al., Sabbah et
al.

Chondrocytes Col2a1, Col10a1, Comp, Eln, Acan, Fn1, Mgp, Sox9, Egr1, Hes1, Tgif1,
Prg4, Ihh, Shox2
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Dehne et al., Xu et al.,
Yu et al., Lin et al.

3.3.8 Histology

Following sacrifice, injured limbs from stress fracture (n = 22) and full fracture (n = 15)
were harvested and placed in 10% neutral buffered formalin for 24 hrs. Tissue was decalcified
for 14 days using 14% EDTA, embedded in paraffin, and longitudinal cuts were made for
histological observation and immunohistochemistry (IHC) processing. Histological sections of
each time point were stained with hematoxylin and eosin (H&E) to show the progression of
healing in each fracture type at each time point in the study (Figure 3.2).
Antibodies for Gr-1 (Bio-Rad MCA2387T, 1:500 dilution), F4/80 (Bio-Rad, MCA497RT
1:500 dilution), and CD45 (BD Pharmingen 550539, 1:500 dilution) were used with an
ImmPRESS Reagent Anti-Rat IgG (VectaShield MP-7404) kit to stain for infiltration of
neutrophils, macrophages, and leukocytes, respectively. An antibody for p-Akt T308 (Cell
Signaling #2965) was used with a goat anti-rabbit/HRP secondary antibody (Dako P0448) in
order to stain for activation of the PI3K-Akt signaling pathway. Sections were counterstained
with hematoxylin (Modified Mayer’s, Electron Microscopy Services). Following staining, slides
were imaged using a Nanozoomer slide scanner (Hamamatsu) at 20X magnification.
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Figure 3.2: Progression of healing of stress fracture and full fracture over time. H&E staining of paraffin sections
of stress fracture or full fracture callus. Scale bars represent 250 μm for stress fracture images and 1 mm for full
fracture images. Ct = Cortical Bone, Ma = Marrow, Mu = Muscle, ▲ = stress fracture or full fracture line, dotted line
= callus.
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3.4 Results
3.4.1 RNA-seq Data Correlates to Previous Fracture Gene Expression Data

Plots of principle components 1, 2, and 3 for all samples in stress fracture (Figure 3.3 A)
and full fracture (Figure 3.3 B) were compiled. Samples clustered by time point and adjacent
time points were closest together on the plots. Additionally, gene expression values from RNAseq and previously published qPCR data were strongly correlated (r = 0.75) and clustered around
the identity line (Figure 3.3 C). Fold changes from qPCR performed on remaining RNA from
full fracture samples also closely corresponded to those from the RNA-seq analysis (Figure 3.3
C). These data supported the accuracy of RNA-seq to describe post-fracture transcriptional
changes, affirmed the integrity of these samples, and confirmed the validity of pooling controls
and samples within time points.
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Figure 3.3: Validation of RNA-seq data. Principle component analysis (PCA) of all samples in stress fracture (A) and
full fracture (B). Samples within time points cluster together and time point clusters were grouped closely with adjacent
time points. (C) Correlation of RNA-seq data with analogous qPCR data from previous published reports of stress fracture
(blue triangle) and full fracture (grey circle) and concurrent qPCR of full fracture samples (red circle). Log2 fold change
(injured vs. control) from RNA-seq was plotted versus log2FC from qPCR (+/- standard deviation). Data is plotted from
multiple time points for each injury. A linear regression confirmed strong correlation between RNA-seq and qPCR data.
Genes from published reports are detailed in Table 3.1. Select genes from concurrent qPCR are labeled with arrows.
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3.4.2 Dramatic Transcription Changes during Fracture Repair

Overall, there were approximately 17,240 genes with high enough expression to be included
in DEG analysis. Of these, 7,383 were differentially expressed genes (DEGs) in at least one time
point and fracture type. Stress fracture repair had few early responding genes with only 87 DEGs
at 4 hours and 124 DEGs at day 1 following injury (Figure 3.4 A). This number increased to
1,099 DEGs by day 3 and peaked with 1,434 DEGs at 5 days post-injury. From 5 to 7 days post
injury, the number of DEGs declined. On the other hand, full fracture resulted in many early
changes in gene expression, with over 2,000 DEGs at 4 hours post-injury (Figure 3.4 B). The
number of DEGs remained high across all time points and peaked at 4,474 DEGs at 7 days postinjury. After full fracture, more genes were downregulated than upregulated across all time
points. In contrast, more genes were upregulated at all stress fracture repair time points.
Gene expression varied greatly across time, with few genes differentially expressed
across all time points. The largest DEG subsets were those unique to only one time point or those
shared by consecutive time points – especially the later ones (Figures 3.4 C & D). For example,
in stress fracture the largest DEG subset is the one shared between days 3, 5, and 7 post-fracture
(571 DEGs). The numbers of DEGs shared between any two time points further highlights that
the greatest number of shared DEGs occurs between adjacent time points (Figure 3.5).
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Across all time points, 1,469 DEGs were shared between stress fracture and full fracture,
while 5,497 DEGs were unique to full fracture, and 210 were unique to stress fracture repair
(Figure 3.6 A). A similar trend was observed for each time point comparison, with the largest
number of DEGs unique to full fracture, a smaller subset shared between the two injuries, and
the fewest DEGs unique to stress fracture. Each subgroup was analyzed for enriched GO terms
and pathways (Figure 3.6 B).
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Figure 3.4: DEG trends across time. Total number of DEGs at each time point are shown for stress fracture (A) and full
fracture (B). Following stress fracture (S.Fx), few DEGs occurred early, but DEGs reached robust levels at later time points
and peaked at day 5. Following full fracture (Fx), DEGs were immediately expressed at high levels that persisted through
our experimental window, and peaked at day 7. Comparisons of the overlap of DEGs at each time point for stress fracture
(C) and full fracture (D) are shown in 5-way Venn diagrams. Total number of DEGs at each time point are shown in
parentheses. The largest lists were those unique to one time point or shared between adjacent time points.
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Figure 3.5: DEG overlap between time points. Number of differentially expressed
genes (DEGs) shared between time points. Grey boxes show the total number of
DEGs in each individual time point, while white boxes show number of shared DEGs
between the two time points.
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Figure 3.6: Comparison of DEGs between fracture types. Comparisons across injury type at various time points
reveal lists of DEGs which are shared between the two injuries or unique to one repair process. (A) The number
of genes shared between injuries at corresponding time points. (B) The top genes, GO terms, and pathways for
each of these lists.
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3.4.3 Stronger Expression Changes in Full Fracture Repair

The top ten up- and downregulated DEGs at every time point were compiled (Table 3.3).
In stress fracture, genes involved in inflammation and matrix degradation were upregulated at
early time points. Among these were Prostaglandin-Endoperoxide Synthase 2 (Ptgs2),
Suppressor of Cytokine Signaling 3 (Socs3), and metalloproteinases Mmp3, Adamts4, and
Timp1. Ras Related Glycolysis Inhibitor and Calcium Channel Regulator (Rrad) was among the
top upregulated genes at H4 and D1 post-stress fracture. Rrad is involved in bone homeostasis
and knockout of Rrad leads to osteopenia [106]. Pannexin 3 (Panx3) and C1q and TNF Related 3
(C1qtnf3) are the top most upregulated DEGs at days 3, 5, and 7 post-stress fracture. Both Panx3
and C1qtnf3 are expressed in osteoblasts [107]. Panx3 is a putative Runx2 target [108] and is
important in osteoblast differentiation and regulation of the Wnt/β-catenin pathway [109]. In the
context of bone, C1qtnf3 is less understood, but may also influence osteoblast differentiation
[110,111]. The greatest FC values occurred at D5, which is also the time point with the largest
number of DEGs. Interestingly, genes associated with chondrogenesis (Col9a1/2/3, Col2a1,
Acan) are highly upregulated despite the relatively small amount of cartilage tissue in the stress
fracture callus [112]. However, these may not necessarily be due to chondrocytes, as osteoblasts
also express these transcripts[107]. Appearing among the early downregulated genes are
Dickkopf WNT Signaling Pathway Inhibitor 1 (Dkk1) and Sclerostin (Sost) – both known
inhibitors of bone formation [113,114].
In full fracture, inflammatory genes exhibited the largest fold changes at the early time
points. Among these were the C-X-C Motif Chemokine Ligands 1, 2, 3 and 5 (Cxcl1, Cxcl2,
Cxcl3, and Cxcl5), which are attractants of immune cells and endothelial cells [36,115,116], as
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well as IL-6, IL-11, and Ptgs2, all important chemokines in bone repair [31,34,35,117,118].
Arginase 1 (Arg1), an essential metabolite in collagen synthesis and wound repair, was also
highly upregulated at several time points [119]. Like stress fracture, the largest FC values
occurred at the penultimate time point (day 7), when there was a large upregulation of
chondrocyte related genes (Col9a1/2/3, Col10a1, Matn1/2); the peak fold changes in
chondrocyte related genes were an order of magnitude greater in full fracture than stress fracture
(e.g., Col9a1: FC = 440, D7 full fracture vs. FC = 35, D5 stress fracture). Among the most
downregulated genes in full fracture repair are those related to myosin (Myl2, Myl3, Myh7, and
Mylk4) and genes from the immunoglobin superfamily (Ly6g6f, G6b, and Gp6).

63

Table 3.3: Top up- and down-regulated DEGs for each injury and time point.
Stress Fracture
Hour 4
Gene

Day 1
FC

Up-regulated

Rrad
4.8
Ptgs2
4.7
Socs3
4.7
Wnt1
4.2
Ngf
4.1
Tnfrsf12a
3.6
Adamts4
3.6
Gm42679
3.5
Has1
3.4
Serpine1
3.1
-2.5
Down-regulated Gng8
Krt75
-2.4
Dkk1
-2.4
Dlx6os1
-2.4
A530020G20Rik -2.3
Gprasp2
-2.3
Hrk
-2.3
Megf6
-2.3
Wscd2
-2.2
Kcnk3
-2.2

Gene

Day 3
FC

Day 5

Day 7

Gene

FC

Gene

FC

Gene

FC

Timp1
6.7
Rrad
6.7
Mmp3
5.2
Has2
5.1
Scn5a
4.9
Socs3
4.5
Pdpn
4.4
Card14
4.4
Myog
4.3
Adamts4
4.1
Nell2
-2.4
A930018M24Rik -2.3
Prss55
-2.3
Klhl33
-2.3
Ces1d
-2.2
Sost
-2.2
Mylk4
-2.2
Klf15
-2.1
Asb15
-2.0
Abca6
-2.0

C1qtnf3
Panx3
Ptgs2
Hapln4
Cthrc1
Tubb3
Timp1
Car12
Acan
Fkbp11
Redrum
Hist3h2ba
F930017D23Rik
Inmt
A730036I17Rik
Rhag
Klhl14
Sowaha
Hbb-bs
Hbq1b

24.8
20.7
17.3
13.3
12.8
11.9
11.5
11.4
9.7
8.7
-3.8
-3.7
-3.7
-3.6
-3.6
-3.6
-3.6
-3.6
-3.5
-3.5

Panx3
C1qtnf3
Col9a3
Col9a2
Col9a1
Hapln1
Ptgs2
Col2a1
Car12
Acan
Cd8b1
Phyhip
Acmsd
Gm42870
Terc
Odf3l2
Redrum
Rhag
2810030D12Rik
Hemgn

88.2
75.0
65.3
62.8
35.2
35.0
34.7
34.3
27.3
24.0
-5.2
-3.6
-3.4
-3.4
-3.4
-3.4
-3.3
-3.3
-3.3
-3.3

Panx3
C1qtnf3
Car12
Col10a1
Col9a2
Col2a1
Cthrc1
Col9a3
Myh8
Bcan
Ighv9-3
Phyhip
Hbb-bs
Ms4a1
Fcmr
Hbb-bt
RP23-171B16.2
Alas2
Iglc2
Cacna1i

24.2
20.9
19.3
14.0
13.1
9.5
9.5
9.4
8.9
8.5
-3.6
-3.3
-3.2
-3.2
-3.1
-3.1
-3.0
-3.0
-3.0
-3.0

Day 1

Day 3

Full Fracture
Hour 4
Gene
Up-regulated

FC

Cxcl2
328.2
Cxcl1
276.9
Csf3
275.0
Il6
183.8
Cxcl3
167.8
Fosb
77.5
Krt81
68.7
Irg1
57.4
Ptgs2
55.5
Ccl2
51.6
Down-regulated 9430073C21Rik -13.3
Pck1
-10.4
Gm28653
-9.9
Adrb3
-9.6
Sln
-9.2
Zic3
-8.1
Dlx6os1
-8.1
Gm10629
-7.9
A930016O22Rik -7.7
A530016L24Rik -7.7

Day 7

Day 14

Gene

FC

Gene

FC

Gene

FC

Gene

FC

Arg1
Il11
Cxcl3
Cxcl2
Ccl7
Ptgs2
Ccl2
Spint1
Cxcl1
Cxcl5
Cyp2e1
Lrrc52
Timp4
Aqp4
Col6a6
Mylk4
A530016L24Rik
Lgi1
Pck1
Ces1d

234.3
188.9
172.2
81.4
63.1
49.1
46.9
32.1
29.9
24.1
-30.0
-19.3
-13.5
-13.3
-12.5
-12.3
-12.2
-11.9
-11.1
-11.1

Gm7325
Arg1
Tmem8c
Chrng
Il11
Steap1
Pkhd1
Has2
Ptgs2
R3hdml
Myl3
Myl2
Myh7
Gm37527
Rp1
BC048679
Lrrc52
Sowaha
Perm1
F930017D23Rik

73.7
59.0
56.0
47.6
47.3
43.3
38.5
35.9
35.6
29.9
-44.0
-40.8
-31.8
-28.4
-25.4
-24.4
-24.2
-23.6
-22.7
-22.3

Col9a1
Ucma
Matn3
Lect1
Clec3a
Col9a3
Col10a1
Mfi2
Matn1
Col9a2
Gp6
Gm43291
Ly6g6f
Ppbp
Slamf1
G6b
Treml1
Tubb1
Gm42870
Gp9

440.5
437.9
434.3
415.2
392.6
375.2
328.1
320.7
316.3
279.9
-43.1
-42.3
-39.6
-37.6
-36.9
-36.8
-35.1
-33.0
-33.0
-32.5

Col10a1
Clec3a
Panx3
3110079O15Rik
R3hdml
Col9a1
Matn1
Col9a2
Mfi2
Lect1
Cyp2e1
Ly6g6f
Gp6
G6b
Mpl
Serpina3b
Gm34302
Gp9
Ppbp
Treml1

97.0
54.0
47.0
43.1
39.8
32.4
27.3
27.0
25.7
24.8
-24.9
-23.9
-21.5
-20.8
-20.2
-19.5
-18.9
-18.8
-17.7
-17.0
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3.4.4 GO Term Analysis

115 GO terms were significantly enriched in at least one time point and fracture type
(Figure 3.7 A). Of these, 17 GO terms were shared between both injuries, while 16 terms were
unique to stress fracture and 82 were unique to full fracture (Figure 3.7 B). Enriched GO terms
were compared across time points and injury type (Figure 3.7 C). Early time points showed no
GO terms that were unique to stress fracture. In contrast, at day 3 through day 7 several terms
related to osteogenesis were unique to stress fracture repair, such as “collagen fibril
organization”, “osteoblast differentiation”, “bone development”, “bone mineralization”, and
“negative regulation of Wnt signaling”.
GO terms shared between stress and full fracture were few at early time points and
included “response to cytokine” and “positive regulation of transcription from Polr promoter” at
4 hours, and “positive regulation of cell migration” at day 1 post injury. Later time points had
shared terms such as “angiogenesis”, “extracellular matrix organization”, “ossification”, and
“cartilage development”.
Terms unique to full fracture repair included those related to inflammation
(“inflammatory response”, “chemokine-mediated signaling pathway”, “cellular response to IL1”, and “innate immune response”), metabolism (“oxidation-reduction process”, “glucose
metabolic process”, and “response to hypoxia”), and ion transport (“potassium ion
transmembrane transport”, “cellular calcium ion homeostasis”, and “ion transport”).

65

Figure 3.7: Gene ontology analysis of DEGs. (A) Pipeline for gene ontology (GO) term analysis. (B) Comparison
of the 115 GO terms uniquely enriched in stress fracture (dark blue), enriched in both injuries (light blue), or
uniquely enriched in full fracture repair (grey). (C) Graphical list of all 115 enriched GO terms across all injuries
and time points. Colors on chart match location of term from panel B. Go terms uniquely enriched in early full
fracture time points were broken out into the smaller sub-panel for figure compactness (Black arrows). Blank
spaces indicate GO term was not statistically enriched at time point or injury. H4 – 4 hour, D1 – day 1, D3 – day
3, D5 – day 5, D7 – day 7, D14 – day 14. S.Fx - stress fracture, Fx- full fracture
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3.4.5 Pathway Analysis

60 pathways were significantly enriched in at least one time point and fracture type
(Figure 3.8 A). Of these pathways, 12 were enriched in both stress and full fracture, while 3 were
uniquely enriched in stress fracture, and 45 were uniquely enriched in full fracture (Figure 3.8
B). Of the three pathways unique to stress fracture, only the “PI3K-Akt signaling pathway” was
enriched at multiple time points (Figure 3.8 C). Pathways that were shared between stress and
full fracture repair include those related to the immune system and diseases (“TNF signaling”,
“cytokine-cytokine receptor signaling”, “systemic lupus erythematosus”, and “malaria”) as well
as pathways like “ECM-receptor interactions”, “focal adhesions”, and “arginine and proline
metabolism”. Pathways uniquely enriched in full fracture repair include those related to immune
processes (“Rheumatoid arthritis”, “NFκB signaling”, “toll-like receptor signaling”), metabolism
(“glycolysis/gluconeogenesis”, “insulin resistance”, “galactose metabolism”) and cardiac muscle
(“hypertrophic cardiomyopathy”, “cardiac muscle contraction”, “calcium signaling”).
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Figure 3.8: Pathway analysis of DEGs. (A) Pipeline for pathway analysis. (B) Comparison of pathways enriched
in stress and full fracture repair. (C) Graphical list of all 60 enriched pathways across injuries and time points.
Colors on chart match location of pathway on panel B. Blank spaces indicate no significance of pathway at that
time point/fracture condition. H4 – 4 hour, D1 – day 1, D3 – day 3, D5 – day 5, D7 – day 7, D14 – day 14. S.Fx stress fracture, Fx- full fracture
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3.4.6 Callus Component Phenotyping

To estimate the abundance of cell types within fracture callus throughout repair, the fold
change of genes on curated lists (Table 3.2) were compiled for each time point and fracture type
(Figure 3.9). Neutrophil related genes were strongly upregulated at early time points (hour 4, day
1) following full fracture (Figure 3.9 A), and slightly increased after stress fracture (hour 4). At
later time points, most neutrophil-related genes were downregulated (days 5, 7, and 14).
Macrophage related genes displayed a mix of up- and downregulation within time points and
thus no clear pattern was evident (Figure 3.9 B). Monocyte related genes were upregulated at
multiple time points in both stress and full fracture, most strongly at early time points (hour 4
and day 1) after full fracture (Figure 3.9 C). T cell associated genes were upregulated early post
stress fracture (hour 4) and full fracture (hour 4 and day 1), but suppressed at later time points
(days 5, 7, and 14) (Figure 3.9 D). B cell related genes were mostly suppressed after stress
fracture (days 1 - 7) and full fracture (days 3 - 14) (Figure 3.9 E). Osteoblast related genes were
strongly expressed after stress fracture (days 3, 5, and 7) and to a slightly lesser extent following
full fracture (days 3, 7, and 14) (Figure 3.9 F); these genes were down early (hour 4) post-full
fracture. Osteoclast related genes did not show strong signal either up or down except for slight
upregulation at the final time point of each injury (Figure 3.9 G). Endothelial cell related genes
showed modest increases by later time points in both models (Figure 3.9 H). Chondrocyte related
genes showed upregulation in both models at later time points (days 5, 7, and 14) (Figure 3.9 I).
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Figure 3.9: Callus component phenotyping heat maps. Heat maps (log2 fold change) were generated for each
time point and injury of curated genes lists associated with (A) Neutrophils, (B) Macrophages, (C) Monocytes,
(D) T Cells, (E) B Cells, (F) Osteoblasts, (G) Osteoclasts, (H) Endothelial Cells, and (I) Chondrocytes. Gene lists
were generated using literature sources in Table 3.2.
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3.4.7 IHC of fracture callus

Antibodies for Gr-1, F4/80, and CD45 were used to stain fracture callus to assess the
presence of immune cells. Gr-1, a marker of neutrophils, was abundantly expressed in marrow in
the contralateral control, but not in cortical bone, endosteum, or periosteum. At early post-injury
time points (hour 4 - day 3) Gr-1 expressing cells were adjacent to the injury site in both stress
and full fracture (Figure 3.10). This signal was diminished at later time points (days 5, 7 and 14)
- consistent with the callus component phenotyping analysis and suggesting a reduced role for
neutrophils after the early injury response. Staining for F4/80, a marker for macrophages,
showed strong signal in the bone marrow of control ulna and femur, but not in cortical bone,
endosteum, or periosteum. Stress fracture repair did not lead to robust F4/80 staining at any time
point, with only modest local staining at hour 4 post-injury; this is consistent with the lack of a
strong macrophage signal from callus component phenotyping analysis. By contrast, in full
fracture, F4/80 staining was present in callus at all time points with the most robust staining at
D3 post-injury. CD45, a general marker of leukocytes, was most abundant at 1 and 3 days post
stress fracture. In full fracture, CD45 showed robust staining at early time points (hour 4 – day 3)
and was reduced by day 7 and 14. In summary, neutrophils abound in early callus of both stress
and full fracture while macrophages appear to be more abundant in full fracture callus than stress
fracture.
To confirm that PI3K-Akt signaling was active in stress fracture repair, we performed
IHC staining for p-Akt T308. Little staining for p-Akt was present in contralateral bone or at day
1 after injury (Figure 3.11). By days 3, 5, and 7 after injury, staining was observed in stress
fracture callus, especially in areas within newly formed bone near the crack.
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Figure 3.10: Immune cell infiltration in fracture callus. Immunohistochemistry with antibodies for Gr-1, F4/80,
and CD45 was used to stain for neutrophils, macrophages, and leukocytes, respectively. Cartoon depictions of the
fracture callus show Region of interest (ROI) (Black box) in reference to (A) stress fracture (S.Fx) or (B) full
fracture (Fx) location. All images are 20X magnifications and black scale bars are 100 μm. Ct = Cortical Bone,
Ma = Marrow, Ps = Periosteum
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Figure 3.11: Activation of PI3K-Akt signaling in stress fracture callus. IHC staining for p-Akt T308 was
performed on paraffin embedded histology slides of stress fracture callus. In contralateral control ulna no staining
is evident in bone tissue, but staining is observed in adjacent muscle tissue. Little staining is observed at day 1
after stress fracture. Staining can be observed within the fracture callus at days 3, 5, and 7 post stress fracture.
Arrows are used to mark examples of positive stained cells. Scale bars are 100 μm in length.
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3.5 Discussion
Our work describes and compares gene transcription in intramembranous and
endochondral ossification using RNA-seq during stress fracture and full fracture repair,
respectively. Several reports have examined gene expression of endochondral [80–84] or
intramembranous repair [29]. However, our study is unique in making direct comparisons
between the gene expression in these two different repair processes. Furthermore, we took a
wider breadth than previous work by tracking gene expression over several time points for each
model. Through analysis of top DEGs, and enriched GO terms and pathways for each fracture
modality, we described how these expression patterns differed and progressed through time. We
also employed callus cellular phenotyping techniques to estimate cell types within callus
throughout repair. Finally, we used IHC to confirm the presence of some immune cell types in
callus and surrounding tissues.
Although some DEGs were shared between stress fracture and full fracture repair, each of
these models show a high level of distinct DEGs. This suggests that some fundamental processes
are necessary for bone repair regardless of injury type – but that endochondral and
intramembranous bone formation also have many distinct processes not shared between these
models. We observed gradual gene expression changes following stress fracture, with few DEGs
at early time points (Figure 3.4 A). However, by day 3 a robust number of DEGs were present at
levels that persisted through our final time point (day 7). Contrastingly, we observed immediate
and drastic changes in gene expression following full fracture, with thousands of DEGs at early
time points, which was sustained at high levels throughout observed time points (Figure 3.4 B).
This higher differential expression following full fracture is likely due to the more extensive
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injury of full fracture, as well as the greater variety of cells involved in endochondral ossification
as compared to intramembranous ossification.
A key difference in gene expression between stress and full fracture arises from the larger
inflammatory reaction in full fracture injury. This is highlighted by GO terms and pathways
uniquely enriched during full fracture repair such as “inflammatory response”, “immune
response”, “cellular response to interleukin-1”, “NFκB signaling” and “Toll-like receptor
signaling”. These results are indicative of a highly inflamed bone microenvironment following
fracture, matching literature reports of the components and importance of the inflammatory
phase of fracture repair [5,120]. Specifically, IL-1 [33,121] and NFκB [120] have already been
studied in endochondral fracture repair and thus validate our highly enriched pathway analysis
for these terms. However, our pathway analysis showed enriched genes associated with toll-like
receptors, which haven’t previously been studied during endochondral fracture. These receptors,
based on other reports, could be involved in monocyte recruitment, osteoblast differentiation,
and tissue repair – however, the specific role they play in fracture repair needs to be further
explored [122,123].
Stress fracture repair also features inflammation, with GO terms and pathways such as
“response to cytokine”, “TNF signaling pathway”, and “Cytokine-cytokine receptor interaction”
shared between both injuries. This pattern of inflammation differs from that in microarray results
of rat stress fracture reported by McKenzie et al, wherein IL-1, toll-like receptors, and NFκB
were more prominently featured among DEGs [29]. Ptgs2 (aka Cox-2), a critical mediator of
inflammation, was one of the most upregulated genes at several time points following stress
fracture and full fracture (Table 3.3), and is a known contributor to successful healing [30,124].
Although it is certainly involved in stress fracture repair, the inflammatory reaction appears to be
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less extensive than after full fracture, both in terms of the numbers of relevant DEGS and their
fold change.
The higher inflammation seen in the GO term and pathway analysis is also observed in
callus cellular phenotyping and IHC analysis of fracture callus. Full fracture has a larger
upregulation of immune-cell related genes as well as greater staining for Gr-1, F4/80, and CD45
than stress fracture (Figure 3.9 & 3.10). Recruitment of neutrophils, macrophages, and
leukocytes to the site of injury at early time points is robust in our dataset. This is indicative of a
healthy repair process, as these cells are important components of fracture repair [21,24,125].
Furthermore, IHC evidence of immune cell recruitment corroborates that the inflammatory signal
in the RNA-seq data is functionally present in fracture repair at the cellular level. In addition, the
callus phenotyping data showed an upregulation of T cell markers at early time points (hour 4
and day 1) following full fracture and to a lesser extent stress fracture. This is consistent with a
report of T cell infiltration at early time points after full fracture [9]. But, how T cells impact
fracture repair remains poorly understood. Reports show that elimination of the adaptive immune
system benefits healing, but other reports show that elimination of certain subsets of T cells are
detrimental to repair [25,126].
Our results indicate that stress fracture repair is a more direct model of post-injury
osteogenesis. GO terms such as “osteoblast development”, “bone development”, “skeletal system
development”, and “bone mineralization” are uniquely enriched following stress fracture
(Figures 3.7 & 3.8). Furthermore, in callus phenotyping, osteoblast associated genes are the
strongest signal for any cell type following stress fracture (Figure 3.9 F). While full fracture is a
mix of several important processes (i.e. osteogenesis, chondrogenesis, and inflammation), these
additional processes can complicate interpretation of experiments designed to test defects in
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ossification. On the other hand, stress fracture repair involves fewer processes and cell types and
therefor elicits strong enrichment of bone cell and osteogenic signals.
While stress fracture is a simplified model of post-injury osteogenesis, it elicits a
distinctive and more complex transcriptional process than non-injurious anabolic bone
formation. Kelly et al. used RNA-seq to determine expression changes in cortical bone following
anabolic loading stimulation [127]. Few of the DEGs in their analysis were DEGs at similar time
points following stress fracture (Figure 3.12). This agrees with previous reports showing stress
fracture-induced intramembranous bone formation is transcriptionally distinct from loadinginduced lamellar bone formation [29].
The PI3K-Akt signaling pathway is the only pathway uniquely enriched at multiple time
points in stress fracture repair (Figure 3.8). We also observed activation of this pathway in stress
fracture callus using IHC (Figure 3.11). Interestingly, this pathway is important for osteoblast
differentiation and function [128,129]. A few studies have examined this pathway in fracture
repair. Qu et al. noted that inhibition of Akt signaling reduces MSC engraftment into fracture
callus in a rescue model for rat non-union [130]. They further postulate that Akt signaling
modulates post-injury osteogenesis via production of osteoprotegrin and bone gla protein.
Furthermore, Scanlon et al. reported that PI3K can regulate thickening of the periosteum during
the early stages of fracture repair [131]. These papers, along with our data, suggest PI3K-Akt
signaling is an important and understudied component of bone regeneration.
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Figure 3.12: Comparison of stress fracture transcriptome to anabolic loading transcriptome. Of the 100
DEGs reported by Kelly et al. to be differentially regulated in cortical bone following anabolic tibia loading, few
are also DEGs following stress fracture. (A) Only 13 DEGs are shared between hour 4 following stress fracture
and hour 3 following tibia loading. (B) Only 4 DEGs are shared between stress fracture and tibia loading on day
1 following each model. (C) Log2 FC for all 100 DEGs reported 3 hours and 1 day after tibia loading in Kelly et
al. and the Log2 FC of those same genes at 4 hours and 1 day after stress fracture.
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Another difference between stress and full fracture repair is the host of ion transportrelated GO terms (“ion transport”, “cellular calcium homeostasis”, “potassium ion
transmembrane transport”) and pathways (“calcium signaling pathway”, “cardiac muscle
contraction”) which are uniquely enriched following full fracture. These terms were triggered by
downregulation of calcium, potassium, and sodium voltage-gated channels (Figure 3.12, Table
3.4). One possibility for this downregulation includes ion channels directly influencing bone
regeneration. Studies show ion channels involved in development and regeneration through
endogenous bioelectrical patterning [132]. In fact, interfering with ion channels causes defective
tail regeneration in amphibians [133]. Ion channels also have roles in bone cells, as potassium
voltage gated channels regulate inflammation-induced bone resorption [134] and sodium voltage
gated channels impact osteoblast function [135]. Reports of ion channels in bone repair have
contradictory results [136,137] and would benefit from future exploration. The downregulation
of ion channels could also involve pain sensation. Sodium, potassium, and calcium channels are
components of pain sensation, and dysregulation of these channels result in painful neuropathies
and hypersensitivities [138–140]. Furthermore, ion channels are downregulated in response to
injury, contributing to post-injury mechanical hypersensitivity [141,142]. Whether ion channels
impact fracture repair through either of these possible mechanisms or through a yet undiscussed
mechanism, their downregulation is robust in full fracture repair and an appealing target for
future study.
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Figure 3.13: Ion channels are downregulated following full fracture. The Log2 FC of Calcium, Potassium, and
Sodium Voltage Gated Channels which were DEGs are displayed across all time points for stress fracture (S.FX)
and full fracture (FX). These channels were disproportionally down-regulated throughout full fracture repair. Due
to these down-regulated DEGs, Go terms and pathways such as “ion transport”, “cellular calcium homeostasis”,
“potassium ion transmembrane transport’, “calcium signaling pathway”, and “cardiac muscle contraction” were
enriched during full fracture repair. A full list of these genes is provided in Table 3.4.

Table 3.4: Genes displayed in comparison of ion channel expression
Group
Ca++

K+

Na+

Gene IDs
Cacna1a, Cacna1b, Cacna1d, Cacna1E, Cacna1S, Cacna2d1, Cacnca2d2, Cacna2d3,
Cacna2d4, Cacnb1, Cacnb3, Cacnb4, Cacng1, Cacng6
Kcna1, Kcna2, Kcna3, Kcna5, Kcna6, Kcna7, Kcnab3, Kcnb1, Kcnb2, Kcnc1, Kcnc2,
Kcnc4, Kcne3, Kcne4, Kcnf1, Kcng4, Knch2, Kcnh7, Kcnj10, Kcnj11, Kcnj12, Kncj15,
Kcnj2, Kncj5, Kcnk13, Kcnk2, Kcnk3, Kcnk7, Kcnn2, Kcnq2, Kcnq4, Kcnq5, Kcns1,
Kcnt1, Kcnt2
Scn1a, Scn1b, Scn2b, Scn3b, Scn4a, Scn4b, Scn5a
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By using a contralateral control of intact bone, which is inherently enriched for bone
cells, callus composed of a variety of cell types will have “differential expression” which is the
result of different cellular composition in addition to true changes in gene expression of native
cells. This should be kept in mind when considering the DEGs represented in this work as this
likely limits our ability to capture expression changes of native bone cells. However, utilizing
this as a feature of our whole callus sequencing allowed us to use callus cellular phenotyping to
infer cell types present throughout fracture repair. Furthermore, it is possible that the surgery
performed while initiating the full fracture could itself influence gene expression when
comparing to a no surgery contralateral control. Despite this possibility, we believe that fracture
is the primary driver of gene expression and is responsible for the large differential expression
reported herein.

3.6 Conclusions
In this report the gene expression of bone repair is examined using two models of murine
fracture repair. Intramembranous repair, as modeled by ulnar stress fracture, and endochondral
repair, as modeled by femur full fracture, exhibit vastly different transcriptional profiles
throughout repair. Full fracture repair includes a much stronger inflammatory response and a
down regulation in ion transporter genes not experienced in stress fracture repair. Within stress
fracture repair is a strong signal of osteoblasts and osteogenesis which reflects a simpler repair
process. These data offer a detailed description of gene transcription in bone fracture repair, and
highlight several pathways and processes as potential new avenues of research that may lead to
innovative solutions to clinical complications in fracture repair.
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Chapter 4: Interleukin-6 (IL-6) deficiency
enhances intramembranous osteogenesis
following stress fracture

4.1 Introduction
Inflammation governs the initial response of the skeleton to injury. This inflammatory
process is a critical component of successful healing and lays the foundation for the subsequent
repair cascade. Of the various stages of fracture healing, the inflammatory phase remains the
least understood. However, various data implicate the importance of this phase to successful
repair. Firstly, inflammation must be tightly controlled both in extent and time-course [11,143].
If the inflammatory process is stunted, for example through use of nonsteroidal antiinflammatory drugs, healing can be negatively influenced [20]. Additionally, if the inflammatory
phase is abnormally high, which can occur in diabetic or obese patients, healing can also be
negatively affected [14,16]. These examples point to the importance of the inflammatory phase
as a critical initiator of the fracture repair process that must be tightly controlled to achieve
optimal healing. A more thorough understanding of the role of the cells and cytokines
contributing to this phase will aid in understanding how the inflammatory phase aids in fracture
repair.
The critical components of the inflammatory phase of repair are still incompletely
understood. Reports have shown that interleukin-6 (IL-6) is an early responding gene transcript
following fracture [28] and stress fracture [29] with substantial transcriptional upregulation
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following skeletal injury. However, the contributions of IL-6 to skeletal repair, particularly
within the inflammatory phase, remain understudied.
IL-6 is a pleotropic cytokine with a multitude of functions across various biological
processes and has been described to have both pro- and anti-inflammatory effects [144]. In nonskeletal injury models, IL-6 has been shown to mediate various inflammatory processes, in
particular IL-6 is a mediatory of the transition between the neutrophil dominated initial response
to a more controlled macrophage dominated response [145,146].
IL-6 is known to play a role in skeletal health [147]. It has long been known that IL-6
promotes osteoclast formation and is associated with many osteoclast mediated bone pathologies
[148,149]. The impact of IL-6 on osteoblasts is less understood and many conflicting reports
exist. Some groups report IL-6 as inhibitory to osteoblast function [150–152] but others show IL6 as a promoting osteoblast function [153].
Previous studies have highlighted that IL-6 knockout mice have delays in endochondral
repair [34,35]. But these studies do little to elucidate the mechanism through which IL-6 impacts
skeletal repair. Furthermore, no studies have examined the role of IL-6 in intramembranous
repair.
In this work, we investigate how IL-6 impacts endochondral and intramembranous bone
formation following injury through the use of IL-6 global and conditional knockout mice. We
take a methodical approach to elucidate the mechanism through which IL-6 plays a role in
skeletal repair by assessing the impact of IL-6 knockout on osteoblast function, osteoclast
function, immune cell recruitment, and production of inflammatory molecules during stress
fracture repair.
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4.2 Methods
4.2.1 Mice
All animal work was performed within an IAUCUC approved protocol. In total, 174 mice
were used. For global knockout studies, IL-6 knockout mice were obtained (Jackson Labs,
#002650) and crossed with wild type C57BL/6J mice (Jackson Labs, #000664) [154]. Breeders
were heterozygotes for IL-6 knockout and littermate IL-6 knockout homozygote (IL-6 KO) or
IL-6 wild type (WT) pups were used in experiments. For conditional deletion studies,
Osteocalcin Cre (#019509) and LysM Cre (#004781) mice were ordered from Jackson Labs and
were crossed to IL-6 floxed mice (European Mouse Mutant Archive, 05332) [155]. All full
fracture and stress fracture experiments were performed on 12 week old animals, while anabolic
loading was performed on 5 month old animals and primary osteoblasts for cell culture were
obtained from 1-3 day old neonates.

4.2.2 Full Fracture
Full fractures were created in the femur mid-diaphysis of mice (N = 19). Detailed
methodology for this procedure has previously been reported [28,44]. In brief, mice were
anesthetized (Isoflurane 1-3%, inhalation), and the right femur was exposed through an incision
and notched at mid-diaphysis to predispose that site to fracture. The right hind limb was then
secured in a custom fixture and a fracture was created via 3-point bending (30 mm/s displacement
ramp) by a material testing machine (Instron Dynamite). Stabilization was achieved through
placement of a 24 G pin into the medullary space, then the incision was closed. Radiographs
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(Faxitron Ultra) were taken to ensure proper fracture location and pin placement and then mice
were returned to unrestricted cage activity until sacrifice. Slow release buprenorphrine (1 mg/kg,
s.c.) was used to control pain.

4.2.3 Stress Fracture

Stress fractures were created in the ulna diaphysis of mice (N = 92) using cyclic forelimb
compression. Cyclic loading for stress fracture creation has been thoroughly detailed in previous
reports [88,89]. Briefly, while anesthetized (Isoflurane 1-3%) the right forearm of the mouse was
secured at the wrist and elbow in custom fixtures on a hydraulic material testing machine (Instron
Dynamite). Force controlled cyclic loading at 2 Hz was performed until reaching a desired
displacement, at which a stress fracture has formed. Loading parameters for each strain were
determined using a set of calibration animals (N = 29) to determine ultimate force of the forelimb
and cyclic displacement to complete fracture of the ulna (Table 4.1). The left ulna served as a
contralateral control. Mice were then administered buprenorphine (0.1 mg/kg, s.c.) and returned
to unrestricted cage activity until sacrifice.

Table 4.1: Stress fracture calibration data for IL-6 mouse strains.

Strain

Ultimate
Force
(N)

IL-6 KO (n = 15)

4.0 ± 0.4

3.0

0.96 ± 0.28

0.48

LysM cKO (n = 6)

3.9 ± 0.4
4.4 ± 0.3

3.0
3.3

0.95 ± 0.15
1.17 ± 0.13

0.48
0.59

Oc cKO (n = 8 )

Cyclic Loading Displacement to Cyclic Stopping
Force
Fracture
Displacement
(N)
(mm)
(mm)
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4.2.4 MicroCT Analysis

Intact femurs were analyzed by microCT to assess if IL-6 knockout had a baseline impact
on bone development. Femurs of IL-6 KO and WT mice were scanned on a Scanco VivaCT
system at power of 55 kVp, intensity of 145 mA, integration time of 300 ms, and voxel size of
10.5 μm. To assess cortical bone, 100 slices surrounding the midpoint of the femur diaphysis
were analyzed for cortical thickness, bone area, marrow area, tissue mineral density and polar
moment of inertia. To assess cancellous bone, 100 slices were analyzed in the distal femur
beginning just proximal to the growth plate. Parameters such as bone volume fraction, bone
mineral density, trabecular thickness, trabecular separation, and trabecular number were obtained
and compared. All parameters were evaluated by 2-way ANOVA with factors of genotype and
sex.
Mice were sacrificed for microCT (μCT) analysis 14 days following full fracture or 7 days
following stress fracture. Full fracture samples had the intramedullary pin removed and were
scanned on a Scanco VivaCT using the same parameters as described for intact femurs. Scans
were manually contoured for callus volume on 600 slices surrounding the mid-point of the
fracture gap. Total volume was calculated as the volume within all contours and bone volume
represented the volume of pixels with densities above a threshold high enough to represent bone.
It is important to note the inclusion of incumbent cortical bone within these measurements,
therefore not all reported bone volume is newly formed after injury. Stress fracture samples
were scanned using a Scanco MicroCT 40 with 70 kVp power, 114 μA intensity, 300 ms
integration time, and 10 μm voxel size. Samples were contoured to select only the new callus for
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analysis and contours were drawn for the entirety of the callus. Total callus volume was the
volume of the contours and the bone volume was the volume within the callus with density over.

4.2.5 Histology

Forelimbs were collected after either 1, 3, or 7 days following stress fracture and fixed in
10% neutral buffered formalin for 24 hours. Following fixation, forelimbs were decalcified by
14% EDTA for 2 weeks. Forelimbs were then embedded in paraffin and sectioned in the
transverse plane at 5 μm thickness. Slides from the 7 day group were stained with TRAP to
identify osteoclast activity within stress fracture callus. Bioquant software was then used to
quantify osteoclast number per bone surface and osteoclast surface per bone surface to compare
between IL-6 KO and WT mice. Slides from the day 1 and day 3 groups were used for
immunohistochemistry to stain for antibodies associated with early responding immune cells in
order to probe if IL-6 KO impacts the recruitment of immune cells to the site of injury following
stress fracture. To identify neutrophils an antibody for Gr-1(Bio-Rad MCA2387T, 1:500
dilution) was used and to identify macrophages an antibody for F4/80 (Bio-Rad MCA497RT,
1:500 dilution) was used. Both of these primary antibodies were used in conjunction with
ImmPRESS Reagent Anti-Rat IgG (VectaShield MP-7404) kit and DAB to stain for their
respective cell type. Slides were then imaged on a slide scanner (Hamamatsu Nanozoomer) at
20X magnification. Neutrophils and macrophages were then quantified using Bioquant software
to obtain measurements of cell density in the calluses of IL-6 KO and WT mice.
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Similarly, day 3 slides were stained for an antibody for proliferating cell nuclear antigen (PCNA)
in order to assess cell proliferation following stress fracture (Cell Signaling Technology
13110T). Proliferating cells were quantified using the IHC plugin for Image J.

4.2.6 Anabolic Tibia Loading

To study the role of IL-6 KO on the anabolic capabilities of osteoblasts, we used the tibia
compression model of loading induced bone formation [156,157]. Mouse hind limbs (N = 22)
were situated in a custom loading fixture at the knee and ankle. Cyclic loading was then
performed at 8 N peak force at 4 Hz for 60 cycles. Loading was performed for 5 consecutive
days (days 1 -5). Calcein (10 mg/kg, i.p.) was administered to mice on day 5 and Alizarin Red
(30 mg/kg i.p.) was administered on day 10 to label newly forming bone matrix. Mice were
sacrificed on day 12 and tibia were processed for plastic embedded histology. Once embedded,
transverse sections were cut 5 mm proximal to the tibial-fibular junction on a microtome and
imaged using a Leica confocal microscope. Calcein and alizarin red labeling were then analyzed
using Bioquant software for parameters such as mineralizing surface, mineral apposition rate,
and bone formation rate [71]. Measurement of mineral apposition rate and bone formation rate
included woven bone. Each parameter was analyzed using a repeated measure 3-way ANOVA
with factors of loading (paired), sex, and genotype. Males and females were then subdivided and
analyzed using repeated measure 2-way ANOVA with factors of loading (paired) and genotype.
To understand the force-strain relationship in this particular mouse line, strain gauging was
performed (N=12) using a previously described method [158].
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4.2.7 Primary Osteoblast Culture
To study if IL-6 knockout impacts the ability of osteoblasts to differentiate and form matrix
we assayed primary calvarial osteoblasts in vitro. Litters of IL-6 KO or WT one to three day old
pups were pooled. Pups were sacrificed by decapitation and calvaria were removed, scraped
clean of connective tissue, and stored in ice cold PBS until digestion. Once all calvaria were
collected, scissors were used to cut calvaria into small pieces. Calvaria pieces then underwent
serial digestion in Collagenase/Dispase (Sigma 11097113001) for 10 min/step at 37 C. Product
from the first digestion was discarded and cells were collected from the subsequent four
digestions. Cells were pooled in αMEM to deactivate collagenase after each digestion. Cells
were then spun down, resuspended in 3 mL growth media (αMEM, 10% FBS, 1% PS) and plated
in a 25 cm flask. Media was changed every other day and cells were checked for confluence.
Upon nearing confluence, cells were trypsinized, counted, and seeded at 50,000 cells/well in a 24
well plate. Following seeding, cells were grown in osteogenic media (growth media with 50
μg/mL ascorbic acid and 3 mM glycerophosphate) for the duration of the experiment. Following
7 days in osteogenic media, cells were stained for alkaline phosphatase activity (Sigma 85L2)
and staining was quantified by a plate reader at 405 nm. Following 21 days of culture in
osteogenic media, cells were stained for mineralization with alizarin red and staining was
quantified following ascorbic acid digestion of alizarin red at 405 nm.
To assess the impact of exogenous IL-6 on osteoblasts in vitro, wild type cells were cultured
as detailed above. Either IL-6 (50 ng/mL, R&D Systems 406-ML), IL-6 soluble receptor (IL-6R,
100 ng/mL, R&D Systems 1830-SR), or the combination of each was added to wells throughout
osteogenic induction and staining for alkaline phosphatase and alizarin were conducted as
previously described. Due to the divergent actions of IL-6 classical and trans signaling on
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osteoblasts, we designed the experiment to test both signaling modalities [153]. The addition of
IL-6 only should recapitulate classical IL-6 signaling through membrane bound receptors on
osteoblasts, IL-6 soluble receptor only will serve as a control, and IL-6 plus IL-6R will
recapitulate trans signaling.

4.2.8 RNA-sequencing

To assess gene expression during the inflammatory phase of stress fracture repair, RNA-seq
was used. Stress fractures were administered to IL-6 KO and control animals who were
sacrificed at either 1 or 3 days post-injury. Ulna were dissected, flash frozen, and RNA was
extracted using the protocol detailed above for tibia. RNA was then delivered to the Washington
University Genome Technology Access Center where samples were sequenced on an Illumnina
HiSeq platform. Reads were aligned to the Ensembl release 76 primary assembly (STAR version
2.5.1a). Gene counts were derived from the number of uniquely aligned unambiguous reads
(Subread:featureCount 1.4.6-p5). Normalization for library size was performed (EdgeR).
Differential expression analysis was then performed to analyze differences between conditions
(Limma).
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4.2.9 IL-6 deletion validation

In order to confirm knockout of IL-6 in global knockout mice, we used lipopolysaccharides
(LPS) to induce inflammation in cell cultures of IL-6 KO and wild type cells [159]. Osteoblasts
were collected and expanded as stated previously (section 4.2.7). Induction of osteogenesis was
begun (day 1) and LPS (5 μg/mL, Sigma L4391) was added to media on day 3, and media was
collected for examination on day 5. An ELISA for IL-6 (Thermo Fisher, KMC0061) was used to
examine IL-6 protein levels in media. Wild type cells had baseline levels of IL-6 around 70 pg/mL
(Figure 4.1). Following LPS treatment, IL-6 significantly increased (p<0.0001) to levels greater
than the detection limit of the ELISA (>500 pg/mL). IL-6 KO cells had baseline levels of IL-6
which were lower than the detection limit of the ELISA (<7.8 pg/mL) and did not significantly
increase (p=0.7513) with LPS treatment. Therefore, we concluded that IL-6 knockout was
confirmed in these global knockout mice.

Figure 4.1: IL-6 KO is confirmed through ELISA. An ELISA for IL-6 was used to assess protein levels in cell
culture media. Wild type mice had detectible levels of IL-6 at baseline which significantly increased with LPS
treatment. IL-6 KO mice had undetectable levels of IL-6 at baseline which did not significantly increase with LPS
treatment. Asterisk (*) denotes p < 0.0001.
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In order to assess the knockdown efficiency of the conditional Cre mouse lines, bone marrow
and tibia samples were collected from Oc cKO, and LysM cKO mice as well as relevant control
animals for each strain. Bone marrow samples were immediately submerged in TRIzol, flash
frozen, and stored at -80 C. Tibia samples were flash frozen and stored at -80 C, pulverized (Braun
Mikrodismembrator), and then dissolved in TRIzol and stored at -80 C until processing. To extract
RNA, TRIzol/sample solutions were processed with an RNA clean-up and concentration kit
(Norgen Biotek). Then cDNA was produced (Bio-Rad iScript) using 500 ng of RNA from each
sample. RT-qPCR was performed (Applied Biosystems StepOnePlus) using primers for IL-6 (Mm.
Pt. 58. 13354106), and reference genes Tbp (IDT, Mm. PT. 39a. 22214839) and Ipo8 (IDT, Mm.
PT. 39a. 22214844). Expression was normalized to reference genes and 2-ΔCt expression values are
reported. Comparisons between knockouts and controls were made using unpaired t-tests.
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4.3 Results
4.3.1 Knockout of IL-6 does not impact skeletal morphology

MicroCT was used to evaluate uninjured femurs from IL-6 KO and WT mice to assess the
skeletal development of IL-6 KO mice at 12 weeks of age (Figure 4.2). Cortical bone parameters
reveal no genotype differences in cortical thickness, bone area, medullary area, tissue mineral
density, or moment of inertia (Figure 4.2 A). Cancellous bone was also similar between
genotypes in parameters such as bone volume fraction, bone mineral density, trabecular number,
trabecular thickness, and trabecular separation (Figure 4.2 B). Two-way ANOVA revealed no
genotype effect in any parameter.

4.3.2 Global knockout of IL-6 does not impair bone formation in
endochondral ossification

Full fractures were created in IL-6 KO and wild type mice and calluses were measured by
microCT 14 days later (Figure 4.3). IL-6 KO mice were able to form callus similar to wild type
mice. Total callus volume, callus bone volume, bone volume fraction, tissue mineral density, and
bone mineral density were all similar between groups (Figure 4.3 B-F).
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Figure 4.2: IL-6 KO did not impair skeletal morphology. MicroCT was used to assess cortical and cancellous
bone in the femurs of 12 week old IL-6 KO and WT mice. Cortical analysis was performed at the femur middiaphysis. A representative reconstruction illustrates a typical sample. Cortical Thickness (Ct.Th), bone area
(B.Ar), medullary area (M.Ar), tissue mineral density (TMD), and polar moment of inertia (pMOI) were similar
between groups. Analysis of cancellous bone was performed in the distal femur. A representative reconstruction
illustrates a typical sample. There were no differences between wild type and IL-6 KO for trabecular (Tb.) bone
volume fraction (BV/TV), bone mineral density (BMD), trabecular number (Tb.N), thickness (Tb.Th), or
separation (Tb.Sp).
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Figure 4.3: IL-6 KO did not alter full fracture callus formation. Day 14 full fracture callus was evaluated using
microCT. (A) Representative wildtype (WT) and IL-6 KO callus reconstructions are shown. Callus total volume
(B), bone volume (C), bone volume fraction (BV/TV) (D), bone mineral density (BMD) (E), and tissue mineral
density (TMD) (F) are not different between groups.
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4.3.3 Global knockout of IL-6 increases callus and bone formation in
intramembranous ossification
Stress fractures were created in IL-6 KO and wild type mice and callus was measured by
microCT 7 days later (Figure 4.4). IL-6 KO mice had significantly larger callus total volume (p =
0.0202) and bone volume (p = 0.0446) than wild type mice, representing an increased capacity
for bone formation after stress fracture (Figure 4.3 B&C). The longitudinal length of the callus
(woven bone extent) was also significantly increased (p = 0.022, Figure 4.3 D). Bone volume
fraction was unchanged between groups. Bone mineral density and tissue mineral density of the
callus were similar between groups. These data indicate that IL-6 KO contributes to larger callus
formation and more bone formation in response to stress fracture, although the callus bone
density is normal.
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Figure 4.4: IL-6 KO increased stress fracture callus formation. Day 7 stress fracture callus was evaluated using
microCT. Representative wildtype (WT) and IL-6 KO callus reconstructions are shown (A). Callus total volume
(B), bone volume (C), and woven bone (Wo.B) extent (D) were all significantly increased in IL-6 KO animals.
Bone volume fraction (BV/TV) (E), bone mineral density (BMD) (F), and tissue mineral density (TMD) (G) were
not different between groups. Asterisk (*) denotes p < 0.05.
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4.3.4 Global knockout of IL-6 does not alter immune cell recruitment in
stress fracture repair
IL-6 has been reported to be a critical mediator of the innate immune system in response to
injury. The transition from neutrophil recruitment to recruitment of macrophages is reliant upon
IL-6 signaling [145,146]. Therefore, we wanted to investigate if IL-6 KO alters the balance of
early responding immune cells in the stress fracture callus. To do so, we used
immunohistochemistry (IHC) staining of day 1 and day 3 stress fracture callus for Gr-1, a marker
of neutrophils, and F4/80, a marker of macrophages. IL-6 KO calluses had similar levels of Gr1+ and F4/80+ cells at both day 1 and day 3 as did wild type calluses (Figure 4.5). Therefore, no
imbalance of early responding immune cells is detected in IL-6 KO.
Two way ANOVA revealed a time effect on immune cell levels in stress fracture callus.
Neutrophils had a significant increase in cell density from 1 to 3 days in the wild type animals (p
= 0.013). IL-6 KO also had increased neutrophil levels, but failed to reach statistical significance
(p = 0.441). Macrophage numbers increased from day 1 to day three in both wild type (p =
0.081) and KO animals (p = 0.020).
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Figure 4.5: IL-6 KO did not alter immune cell recruitment after stress fracture. Day 1 and 3 stress fracture
callus were evaluated using IHC for a neutrophil (Gr-1) and macrophage marker (F4/80). Representative images (A)
demonstrate typical callus morphology at each time point including cortical bone (Ct), stress fracture crack (Sfx)
and surrounding muscle (Mu). The black box represents general location of more magnified representative images
(B) of callus shown for each genotype, time point, and antibody which demonstrate typical levels of staining.
Quantification revealed no change in neutrophil (C) or macrophage (D) levels between genotypes. Scale bars are
100 μm length. * denotes p < 0.05 vs. day 1, # denotes p < 0.1 vs. day 1.
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4.3.5 Global knockout of IL-6 decreases inflammatory and increases cell
proliferation associated gene expression

We used RNA-seq to compare gene expression between IL-6 KO and wild type mice
following stress fracture. Initial comparisons were conducted between day 1 and day 3 time
points for IL-6 KO vs. wild type animals. However, no genes reached statistical significance
(FDR < 0.05) to qualify as differentially expressed genes (DEGs) when comparing directly
between genotypes.
Therefore, in order to make comparisons between genotypes, we generated lists of
differentially expressed genes for each group against non-injured controls of the same genotype.
We then made comparisons between those lists. The top DEGs for each time point and genotype
reveal many similar genes that were most highly upregulated in both KO and WT animals (Table
4.2).
Venn diagrams were generated to show the number of shared and unique DEGs for each
genotype at day 1 and day 3 time points (Figure 4.6 A). At 1 day, 546 DEGs were shared
between the genotypes, while 461 DEGs were unique to wild type mice and 321 DEGs were
unique to IL-6 KO. At day 3, there were 1769 genes were shared as DEGs, while 847 were
unique to wild type and 725 were unique to IL-6 KO. The genes that were shared between
genotypes were plotted according to their fold change (Figure 4.6 B). Genes such as Reg3g and
Wnt1 were more highly expressed in KO callus than WT callus, meanwhile Matn3 was more
highly expressed in WT callus. Each genotype and time point were evaluated for enriched
biological process gene ontology terms as compared to non-injured controls (Figure 4.6 C).
Inflammatory processes such as “inflammatory response”, “immune response”, and “cytokine
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production” were more highly enriched in wild type than IL-6 KO. Terms such as collagen
organization, bone development, and ossification were also more highly enriched in wild type
than knockout. Proliferation processes such as cell cycle, DNA replication, and cell division
were more highly enriched in IL-6 KO than wild type.
In total, these data suggest a less pronounced inflammatory reaction in IL-6 KO mice
following stress fracture. Furthermore, IL-6 KO has increased enrichment for proliferation
related genes. Finally, a handful of genes such as Wnt 1, were more highly upregulated in KO
callus.

Table 4.2: Top up- and down-regulated DEGs for each genotype and time point.
WT D1
Up-regulated

Down-regulated

KO D1

WT D3

Gene

Linear FC

Gene

Linear FC

Linear FC

Gene

Linear FC

Il11

27.9

Reg3g

55.9

Matn3

76.8

Car12

36.0

Reg3g

24.4

Il11

22.8

Car12

29.3

Reg3g

35.5

Saa3

21.7

Saa3

12.7

Ptgs2

20.3

Panx3

31.9

Cldn2

12.1

Wnt1

12.5

C1qtnf3

18.1

Steap1

21.8

Ccl7

11.0

Ccl7

12.5

Panx3

17.8

Hapln4

17.8

Ptgs2

10.5

Cldn2

11.4

Steap1

16.9

Mymk

17.3

Il6

8.9

Steap1

9.2

Reg3g

13.9

Drd4

17.2

Mt2

8.6

Ptgs2

9.2

Saa3

13.3

Ptgs2

15.4

Ccl2

8.6

Cxcl1

9.2

Scn1a

13.2

C1qtnf3

14.8

Timp1

7.5

Prg4

9.0

H2-Pb

12.4

C2cd4a

12.2

Inmt

-8.9

Inmt

-8.1

Ankrd2

-9.0

Ighv5-16

-17.8

Gkn3

-3.6

Dsp

-7.1

Dsp

-7.4

Dsp

-8.3

Gsta3

-3.4

Nyap2

-3.7

Cidea

-6.9

Adrb3

-5.2

Stmn4

-3.3

Krt75

-3.3

Cst6

-6.4

Dmkn

-4.9

Col6a6

-3.2

Col25a1

-3.3

Fa2h

-6.0

Krt75

-4.9

Crym

-3.2

Gm10115

-3.2

Cyp2e1

-5.6

Cidea

-4.7

Fgf23

-3.1

Cdsn

-3.0

Gsta3

-5.6

Inmt

-4.5

Sbk3

-3.0

Fa2h

-2.9

Adrb3

-5.3

Fgf23

-4.5

Kera

-2.9

Cyp2e1

-2.9

Tmem179

-5.1

Cyp2e1

-4.5

Gm29183

-2.8

Hpse2

-2.8

Cdsn

-5.1

Ighv1-39

-4.4
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Gene

KO D3

Figure 4.6: IL-6 KO had more proliferation and less inflammatory gene expression after stress fracture.
Day 1 and 3 bulk tissue stress fracture callus was evaluated for gene expression using RNA-seq. Differentially
expressed genes (DEGs) were found for each genotype and time point though comparison to uninjured control of
same genotype. Comparisons of DEG lists at Day 1 and 3 reveal the largest number of DEGs are shared between
genotypes, but many DEGs are unique to one genotype (A). DEGs that were shared by both genotypes were
graphed by log2 fold change (FC) and reveal several genes which have greater increases expression in KO (B).
Enriched biological process gene ontology terms were compared between genotypes (C). KO samples were more
enriched for proliferative terms, while WT samples were more enriched for inflammatory terms and bone related
terms.
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4.3.6 Global knockout of IL-6 does not alter osteoclasts activity in stress
fracture repair

IL-6 is reported to be important in osteoclast development. Therefore, we wanted to
investigate the possibility that the increased bone in IL-6 KO callus was the result of decreased
levels of bone resorbing osteoclasts. To assay this, we used TRAP staining on histology slices of
day 7 stress fracture callus (Figure 4.7). Quantification of TRAP+ osteoclasts does not show any
change in normalized osteoclast number (#/mm bone surface) or osteoclast surface fraction.
Therefore, changes in osteoclast numbers are likely not the cause of increased bone formation
after stress fracture.

Figure 4.7: IL-6 KO does not alter osteoclast numbers in stress fracture callus. Day 7 stress fracture callus
was evaluated using TRAP staining of histology sections to visualize osteoclasts. Representative images of a wild
type callus (A) and IL-6 KO callus (B) demonstrate typical callus morphology including original cortical bone
(Ct), stress fracture crack (Sfx), and callus woven bone (Wo.B). TRAP is visualized as pink staining and slides
were counter stained with hematoxylin. Quantification revealed that normalized number of osteoclasts to bone
surface (C) and osteoclast surface fraction (D) were consistent between genotypes. Scale bars are 100 μm in length.
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4.3.7 Global knockout of IL-6 increases capacity for woven bone formation in
vivo

Based on increased bone in stress fracture callus, we hypothesized that IL-6 KO may
increase the ability of osteoblasts to produce new bone matrix. To test this idea, we employed a
tibia model of anabolic loading in order to stimulate bone formation in the absence of an injury
response. This allowed us to test the impact of IL-6 KO on osteoblast function, without the
confounding factors of immune cell recruitment and release of inflammatory molecules
associated with stress fracture repair.
Male and female IL-6 KO and wild type mice were all cyclically loaded to 8 N force for this
experiment. Post-hoc strain gauge experiments revealed males (both KO and WT) reached
tensile strain levels of approximately 1000 με, while females reached tensile strain levels of
approximately 2000 με (Figure 4.8).
A 3-way ANOVA with factors of loading, sex, and genotype was performed on the primary
three outcomes from dynamic histomorphometry (mineralizing surface, mineral apposition rate,
and bone formation rate). Sex and Loading-Sex interaction were significant for all outcomes.
Therefore, with these data in combination with the strain gage data, we determined to analyze
male and female groups independently.
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Figure 4.8: Post-hoc tibia strain gauging revealed males and females were loaded to different strains. 5
month old mice were used for strain gaging to assess the response of the mouse tibia to cyclic compression. Strain
and force relationship (A) shows males and females reside on different lines, but genotypes within sex are closely
related. Regression equations were calculated and estimated strain for male and female groups are shown (B),
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Male animals were found to be loaded to a relatively low strain stimulus, which was capable
of triggering modest lamellar bone formation (Figure 4.9 A). Mineralizing surface was nonsignificantly increased in the loaded limbs of male mice as compared to non-loaded controls, but
no genotype difference was detected by 2-way ANOVA (Figure 4.9 B). Mineral apposition rate
and bone formation rate were significantly increased in the loaded limbs of IL-6 KO males, but
not wild type, as compared to non-loaded limbs. Knockout loaded limbs, though modestly
greater, were not significantly different than wild type loaded limbs. Therefore, in bones
stimulated with low strain, there was no significant difference in lamellar bone formation
between IL-6 KO and wild type mice.
Female animals were loaded to a higher strain stimulus, capable of producing consistent
lamellar bone formation and some limited woven bone formation (Figure 4.9 A). For both wild
type and IL-6 KO mice, loaded bones had significantly greater mineralizing surface, mineral
apposition rate, and bone formation rate than did non-loaded limbs (Figure 4.9 B). There was no
genotype difference detected in mineralizing surface. But IL-6 KO animals had higher levels of
mineral apposition rate and bone formation rate than did wild type animals. This was primarily
driven by an increased capacity for knockout animals to form woven bone. Therefore, in bones
stimulated with high strain, there was a significant increase in the ability of IL-6 KO animals to
create bone, especially woven bone.
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Figure 4.9: IL-6 KO mice have increased woven bone formation following anabolic loading. Tibia
compression was used to stimulate loading induced bone formation in 5 month old IL-6 KO and WT mice.
Representative images of each sex and genotype (A) demonstrate greater bone formation observed in female mice
and greater woven bone formation in female KO mice. Dynamic histomorphometry using calcein and alizarin
labels allowed quantification of bone formation parameters. In males, the only significant difference between nonloaded and loaded limbs was observed in knockout animals for mineral apposition rate and bone formation rate.
For females significant increases were observed for each parameter and genotype between non-loaded and loaded
limbs. KO mice also had significantly greater mineral apposition rate and bone formation rate as compared to wild
type mice. * denotes p < 0.05 vs. non-loaded group, # denotes p < 0.05 vs. wild type loaded group.
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4.3.8 Global knockout of IL-6 does not impact in vitro osteogenesis

We also examined the implications of IL-6 KO on osteoblasts using an in vitro culture
model of osteogenesis. Because IL-6 KO mice had an increased capacity for bone formation
following stress fracture and tibial loading, we hypothesized that IL-6 KO primary murine
osteoblasts would have increased osteoblast differentiation and mineralization in vitro. IL-6 KO
and wild type osteoblasts were collected from neonate pups and grown in culture. Upon addition
of osteogenic media, staining for alkaline phosphatase was performed at day 7 and staining for
alizarin red was performed at day 21 (Figure 4.10 A). Semi-quantitative analysis was performed
using a plate reader for absorbance at 405 nm. IL-6 KO and wild type cells had similar levels of
alkaline phosphatase and alizarin red staining (Figure 4.10 A). Therefore, the baseline
performance of primary osteoblasts was comparable between IL-6 KO and wild type cultures.
We then investigated how IL-6 signaling impacted osteogenesis by dosing cells with
exogenous IL-6 and its soluble receptor. Cells dosed with IL-6 only or IL-6 soluble receptor only
had similar levels of alkaline phosphatase staining as vehicle dosed controls (Figure 4.10 B).
However, cells dosed with the combination of IL-6 and soluble had significantly higher levels of
alkaline phosphatase and alizarin red staining. Thus, IL-6 signaling appears to enhance in vitro
osteogenesis in these culture conditions.
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Figure 4.10: IL-6 KO does not impact in vitro osteogenesis. Calvarial osteoblasts were collected from wild
type and IL-6 knockout mice and grown in culture. Following introduction of osteogenic media, alkaline
phosphatase activity was measure at day 7 and alizarin red staining was measured at day 21. In baseline
conditions, using only osteogenic media, no differences were detected in the alkaline phosphatase or alizarin red
staining of WT or KO mice (A). A similar experiment was conducted with the continuous dosing of exogenous
IL-6, IL-6 soluble receptor (IL-6 R), or a combination of the two (B). Neither IL-6 or IL-6 R alone altered
alkaline phosphatase or alizarin red. But the combination of IL-6 and IL-6 R led to increased alkaline
phosphatase and alizarin red staining. * denotes p < 0.05 vs vehicle group.
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4.3.9 PCNA staining is unchanged in IL-6 KO stress fracture callus

We used staining for PCNA on slides of day 3 stress fracture callus to assess the
proliferation of cells in IL-6 KO and wild type mice (Figure 4.11). Similar levels of PCNA
positive cells were observed in the stress fracture callus of IL-6 KO and WT mice.

Figure 4.11: IL-6 KO does not alter PCNA staining following stress fracture. Day 3 stress fracture callus was
evaluated for PCNA staining, a marker of cell proliferation, by IHC. Representative images of a WT (A) and KO
(B) callus display typical staining intensities. Quantification of PCNA + cells (C) do not show any statistical
difference between WT and KO callus. Scale bars are 100 um in length.
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4.3.10
Condition deletion of IL-6 from osteoblasts or myeloid cells does
not recapitulate the global knockout phenotype

In order to study the importance of IL-6 from different cell types, we generated conditional
knockout mice which deleted IL-6 in the osteoblast lineage (Oc Cre) or the myeloid lineage
(LysM Cre). Knockdown efficiency of these strains were assessed in two tissues of interest, bone
marrow and cortical bone (Figure 4.12 A). Oc Cre driven deletion of IL6 had no effect on IL-6
expression in bone marrow, but expression of IL-6 in cortical bone was reduced by 67% (p =
0.003). LysM Cre significantly reduced IL-6 expression in bone marrow by 98% (p = 0.008), and
also caused a non-significant reduction in cortical bone (p = 0.186). Cre mice for both strains
were bred with Td tomato expressing Ai9 transgenes to confirm spatial expression of Cre activity
(Figure 4.12 B). Oc Cre was widely expressed in osteocytes, endosteum, periosteum, and
throughout the woven bone surface of stress fracture callus. LysM Cre had Td tomato expression
in bone marrow as well as sparse expression throughout the stress fracture callus. Stress fractures
were generated in these strains and bone formation was measured with microCT 7 days later.
Neither total callus volume nor bone volume were different between Oc cKO or LysM cKO and
their respective controls (Figure 4.12 C).
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Figure 4.12: Conditional deletion of IL-6 with OC Cre or LysM Cre does not alter stress fracture callus
formation. Deletion of IL-6 was assessed in two target tissues, bone marrow and cortical bone for both strains
(A). OC Cre demonstrated 67% knockdown in cortical bone, while LysM Cre demonstrated 98% knockdown in
bone marrow. Td tomato expression as observed by transverse histology of day 7 stress fracture callus shows OC
cre driven expression throughout cortical bone and callus woven bone (B). LysM driven Td tomato expression
was observed in the bone marrow and also sparsely throughout the callus (B). MicroCT was used to analyze stress
fracture callus morphology at day 7 (C). Neither total callus volume nor bone volume were altered by conditional
deletion of IL-6.
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4.4 Discussion
Following skeletal injury, a crucial inflammatory phase is the first stage of successful
repair. A component of this phase, IL-6 is highly upregulated following fracture. However, by
what means IL-6 affects subsequent bone formation and fracture repair remains incompletely
understood. Therefore, we sought to examine the role of interleukin-6 (IL-6) in post-injury bone
formation.
Following stress fracture, IL-6 KO mice were found to have enhanced capacity for bone
formation. Specifically, IL-6 KO mice on average made 41% larger callus which contained 32%
more bone (Figure 4.4). These calluses also extended further along the longitudinal length of the
bone as did wild type callus. This represents an increased capacity for repair in IL-6 KO mice in
response to stress fracture and suggests that IL-6 may be an inhibitor of intramembranous bone
formation.
Due to the pleotropic nature of IL-6, a multitude of potential mechanisms were
hypothesized for enhanced bone formation following stress fracture. Firstly, we postulated that
IL-6 KO was directly altering the inflammatory phase of repair. This could be done through
disruption of a balanced recruitment of important early responding immune cells, or through
alterations in inflammatory signaling present in the early callus. Secondly, we speculated that IL6 KO could impact the formation of the bone callus directly. This could be achieved by
decreasing the effectiveness of osteoclasts to remodel and resorb newly formed bone or by
enhancing the ability of osteoblasts to create new bone matrix. We explored each of these
theories in subsequent experiments.
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It has been reported that IL-6 is directly involved in the chemotaxis of early responding
immune cells to sites of injury [146]. Therefore, we chose to analyze the levels of neutrophils
and macrophages in the stress fracture callus of early time points (day 1 and day 3 post-injury).
We used IHC of Gr-1 and F4/80, which are known markers for neutrophils and macrophages
respectively. We did not observe any genotype driven differences in the level of Gr-1 or F4/80
positive cells in stress fracture callus (Figure 4.5). This indicates that there was no change in
recruitment of neutrophils and macrophages due to IL-6 KO.
The release of inflammatory cytokines and the relay of inflammatory signaling cascades
are important processes in the inflammatory phase. Knowing that IL-6 is a component of this
phase, we hypothesized that gene expression could be altered in the callus of IL-6 KO mice. To
examine this, we used RNA-seq to appraise gene expression in bulk callus tissue of day 1, day 3,
and uninjured IL-6 KO or wild type mice. IL-6 KO did not result in drastic changes in gene
expression in stress fracture callus. In fact, in direct comparisons between day 1 KO vs. WT
callus, and day 3 KO vs. WT callus, no genes met statistical significance for differential
expression (FDR < 0.05).
When comparing each genotype to its own respective non-injured control there was an
abundance of differential gene expression (Table 4.2 & Figure 4.6). We were then able to make
comparisons between the DEGs and enriched biological process gene ontology terms (BP GO
terms) between these subsets. There was overlap between these DEG lists, but a sizable number
of genes were DEGs for only one genotype. DEGs shared between WT and KO were plotted by
fold change value. A handful of genes, including Wnt1 and Reg3g, had greater upregulation in
KO than WT at both day 1 and day 3. Wnt1 is a potent bone anabolic agent and is associated
with bone formation [160,161]. Regenerating family member 3 gamma (Reg3g) is a bactericide
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with reported involvement in the regeneration of several tissues, however its role in fracture
repair is not reported [162,163]. Higher upregulation of Wnt1 and Reg3g could play a role in the
greater bone formation observed in KO mice.
Enriched GO terms were also compared between genotypes. GO terms related to
proliferation such as “cell cycle”, “DNA replication”, and “cell division” were more highly
enriched in KO callus tissue. Proliferation is an important process in the production of woven
bone [164]. An increase in proliferating osteoblasts could in part explain the increased woven
bone produced in IL-6 KO mice following stress fracture. GO terms related to inflammation such
as “immune response”, “inflammatory response”, “cytokine production”, and “innate immune
response” were more highly enriched in wild type callus tissue. This is suggestive of a slightly
weakened inflammatory reaction to injury in IL-6 KO mice and may be representative of
“missing IL-6 signaling” in these mice. It could be that this modest reduction in inflammation is
a better precursor to bone formation than the wild type reaction and thus leads to greater bone
formation.
IL-6 is known to stimulate osteoclast formation [148,149]. Therefore, it was hypothesized
that IL-6 KO mice, in response to stress fracture callus formation, may have a decreased capacity
to produce osteoclasts. Osteoclasts play an important role in reshaping callus as it forms and
eventually in remodeling the fracture callus in the resolving phase of fracture repair. Although
osteoclasts likely do not play an outsized role as early as day 7 – a time point when callus is still
growing rapidly – it remains possible that a decrease in osteoclasts could in fact lead to an
increase in bone present in callus. To assess osteoclast numbers, we used TRAP staining on
histology of day 7 stress fracture callus (Figure 4.7). We did not observe a change in either
osteoclast number or osteoclast surface per bone surface in the woven bone of stress fracture
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callus in IL-6 KO mice. Therefore, it is unlikely changes in osteoclast formation are responsible
for the increased callus and bone in IL-6 KO mice.
It was also a possibility that IL-6 has a direct impact on osteoblasts in stress fracture
repair. Therefore, we hypothesized that IL-6 KO rendered osteoblasts more capable of producing
bone matrix than wild type osteoblasts. To examine this, we employed both in vivo and in vitro
experiments.
To examine the impact of IL-6 KO on osteoblasts in vivo, we chose to employ a tibia
compression model of loading induced bone formation. This model allowed us to examine how
osteoblasts respond when challenged with a loading stimulus, but without the confounding
factors of injury induced inflammation. Thus, using this model, we hoped to gain an
understanding of how IL-6 directly impacts osteoblast function. Males and females were both
loading to an 8 N stimulus for these experiments. Strain gaging was performed subsequent to
bone formation experiments, and although there were no genotype driven differences in strain
response, it was revealed that males and females had very different strain responses to the 8 N
stimulus (Figure 4.8). We estimated that Females experienced ~2000 με at the 8 N force
stimulus, while, males experienced ~1000 με at 8 N force. Due to this different strain response to
loading – females and males were analyzed separately as a high and low stimulus group
respectively.
Dynamic histomorphometry was used to observe and quantify loading induced bone
formation. Male mice, which received a “low” stimulus had a modest response to loading (Figure
4.9). Mineralizing surface, mineral apposition rate, and bone formation rate were increased with
loading in both genotypes. However, only mineral apposition rate and bone formation rate in
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knockout animals reached significance over non-loaded controls. IL-6 KO and WT loaded limbs
were not significantly different for males. Female mice received a “high” stimulus and had a
significant response to loading for both genotypes for mineralizing surface, mineral apposition
rate, and bone formation rate (Figure 4.9). Furthermore, among loaded limbs, IL-6 KO had
significantly higher mineral apposition rate and bone formation rate than did wild type animals.
This increased response was mostly due to an increased propensity for woven bone formation in
IL-6 KO mice. In fact, if mineral apposition rate and bone formation rate are calculated using
only lamellar bone, and not adjusted to include woven bone, the difference between WT and KO
becomes non-significant. Four samples of the 5 KO samples experienced woven bone formation
while only one of the five WT samples had woven bone formation. Taken together, these data
suggest that IL-6 KO mice are more capable of woven bone formation. This is complimentary to
the increased bone formation observed in stress fracture callus, where bone formation is
primarily woven bone. Meanwhile, IL-6 KO does not appear to impact lamellar bone formation,
as observed in the male cohort. This is complimentary of the baseline skeletal phenotyping
which indicates IL-6 KO mice have normal bone parameters.
To examine how IL-6 KO affects osteoblasts in vitro we used a culture model of
osteogenesis with calvarial osteoblasts from IL-6 KO and WT mice. We measured two relevant
outcomes for osteoblast function, alkaline phosphatase staining – an early marker for osteoblast
differentiation, and alizarin red staining – a marker for matrix production and mineralization
which characterizes osteoblast function. Osteogenic media was used to induce in vitro
osteogenesis in these cells. The baseline ability osteogenesis of IL-6 KO was not different from
WT cells (Figure 4.10 A). KO cells displayed equivalent levels of alkaline phosphatase and
alizarin red staining as did control cells. These data paralleled data showing in vivo skeletal
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development was not impacted by IL-6 KO. Therefore, we wanted to challenge these cells with
some inflammatory stimulus which might better recapitulate what is experienced by osteoblasts
in response to stress fracture. To do this, we turned to a model of exogenous IL-6 signaling in
our in vitro osteogenesis system. We hypothesized that if IL-6 KO was advantageous to bone
formation (as observed post-stress fracture and tibial loading) then it stood to reason that adding
IL-6 to osteoblast cultures would have the opposite effect and would be deleterious to
osteogenesis. To test this, we dosed wild type cell cultures with IL-6, IL-6 soluble receptor, or a
combination of the two. We observed increased alkaline phosphatase and alizarin red staining in
cells treated with the combination of IL-6 and soluble receptor (Figure 4.10 B). This represents
an increased capacity for in vitro osteogenesis in the presence of IL-6 trans-signaling and was
contrary to our hypothesis.
Reports in the literature on the impact of IL-6 on osteoblasts contain many conflicting
reports. IL-6 has been demonstrated to both decrease osteoblast function [150–152] and increase
osteoblast function [153]. These data in combination with our in vitro studies suggest the
implications of IL-6 for osteoblasts are highly context dependent. It is unlikely that in vitro
osteogenesis through osteogenic media induction closely matches the in vivo context of stress
fracture repair. Therefore, while an intriguing complimentary experiment, these data likely do
not shed much light on post-injury bone formation.
Proliferation is an important process for woven bone formation [164]. Increased woven bone in
IL-6 KO mice formation following stress fracture and tibia loading could in part be explained by
increased proliferation of osteoblasts. Furthermore, gene expression in early stress fracture callus
revealed IL-6 KO mice having increased enrichment for proliferation related gene ontology
terms (Figure 4.6). Therefore, we wanted to examine cell proliferation in response to stress
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fracture in IL-6 KO mice. To do this, we used IHC staining for PCNA on day 3 stress fracture
callus (Figure 4.11). However, quantification of PCNA + cells in stress fracture callus does not
indicate any difference in proliferation exists between WT and IL-6 KO callus.
We observed differing phenotypes for IL-6 KO mice in response to full fracture and
stress fracture. Through microCT evaluation of day 14 full fracture callus, no differences were
observed between IL-6 KO and wild type callus (Figure 4.3). This suggests that IL-6 may act in
different manners in endochondral versus intramembranous bone formation. It should be noted
that this was an evaluation of only one time point, and effects of IL-6 KO could possibly impact
different stages of full fracture repair that we didn’t assay.
Knowing that IL-6 KO is capable of increased bone formation in stress fracture callus,
we wanted to know what the cellular source of IL-6 was in response to injury. Are bone cells the
master regulators of bone fracture repair, or are infiltrating immune cells or other cell sources
responsible for initiating successful repair. In an attempt to answer this question, we generated
two conditional deletion (cKO) mouse strains. Oc Cre mice were used to delete IL-6 from mature
osteoblasts and osteocytes and LysM Cre was used to delete IL-6 from myeloid derived cells
such as neutrophils and macrophages. Neither strain of cKO mice recapitulated the increased
bone formation observed in the global knockout mice. Many possible explanations exists for why
this occurred. Firstly, IL-6 could be supplied by a combination of various cells types which could
compensate when one source is depleted. Secondly, it is possible neither of our cell population
targets is a critical source of IL-6 post-stress fracture and an untested population could be
involved. Osteoblast precursor cells, which are not yet Oc +, could fit this role and Osx Cre
could have been used to assess. Lastly, we could have targeted the correct cell populations, but
did not achieve great enough deletion efficiency to recapitulate the phenotype. Whichever of
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these possibilities hold true, the cell population which produces IL-6 following skeletal injury
remains unknown.
Yang and colleges were the first to study fracture repair in IL-6 KO mice [34]. They
reported that 2 weeks following a full fracture, KO mice had reduced mineralization in callus
tissue and that KO callus had increased cartilage content. These differences disappeared by the 4
week time point. Therefore, Yang et al. report that IL-6 deletion delays fracture repair [34]. A
subsequent report by Wallace et al. reported that at 2 week following a tibia full fracture, IL-6
KO had reduced callus strength [35]. Together, these reports paint a picture of delayed bone
healing in IL-6 KO mice. However, in our model of full fracture repair we did not detect any
change in callus morphology for IL-6 KO mice at a two week time point.
A few other reports have studied the role of IL-6 in fracture repair using pharmacological
approaches. Prystaz et. al report that inhibition of IL-6 classical signaling through antibody
injections results in delayed fracture healing. However, Kaiser et al., in a model of polytrauma
and fracture, reported that inhibition of IL-6 trans signaling improved healing outcomes.
Therefore, in it appears that the impact that IL-6 has in fracture repair is very context dependent.
The age of the animal, the particulars of the injury, the method of ossification, and complications
such as polytrauma can all provide varied results for IL-6 inhibition in fracture repair.
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4.5 Conclusions
Herein, we report that IL-6 KO enhances bone formation in a stress fracture model of
intramembranous ossification. IL-6 KO mice produced larger stress fracture calluses which
contained more bone than control mice. There was no change in the recruitment of neutrophils or
macrophages nor was there a change in osteoclast numbers in IL-6 KO stress fracture callus. IL6 KO resulted in slight changes in gene expression following injury, with increased enrichment
in cell proliferation gene ontology terms and decreased inflammatory terms. IL-6 KO also had
greater fold changes in the bone anabolic gene Wnt1. A model for loading-induced bone
formation revealed that osteoblast ability to produce woven bone was enhanced in IL-6 KO mice
in the absence of injury.
In total, we have found that IL-6 KO mice have greater bone formation in response to stress
fractures, through increased proliferation gene expression, decreased inflammatory gene
expression, and an enhanced capacity for osteoblast driven woven bone creation.
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Chapter 5: Cxcr2 deficiency decreases
intramembranous osteogenesis following
stress fracture

5.1 Introduction
Inflammation is a critical process for successful skeletal repair following injury. This
inflammatory stage of repair is tightly controlled in both extent and time course [10,11]. An
inflammatory reaction which is too great can be detrimental to healing. This has been shown
clinically in reports of hyper-inflammation in patients with polytrauma [12,13], obesity [14], or
diabetes [15,16]. On the other hand, an inflammatory reaction which is insufficiently strong will
also lead to sub-optimal repair. This has been reported clinically in patients with HIV [17] and
those treated with NSAID drugs [18–20]. Therefore, a high clinical importance exists for a
thorough understanding of the inflammatory phase of fracture healing and how it facilitates a
successful repair cascade.
Previous data from our lab have shown that the CXC family of chemokines are among
the most highly upregulated genes following skeletal injury [28]. Despite their abundance in the
inflammatory phase of repair, little is known about the role these ligands may play in successful
repair.
The CXC chemokines most upregulated following skeletal injury (Cxcl1, Cxcl2, Cxcl3,
and Cxcl5) all signal through CXC receptor 2 (Cxcr2). These chemokines are reported to mediate
the recruitment of neutrophils from the bone marrow to circulation in order to respond to injured
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tissue [115]. CXC signaling through CXCR2 is also involved in recruitment of endothelial cells
as a mediator of angiogenesis [116]. Because of the importance of neutrophil recruitment [165]
and angiogenesis [166,167] for successful fracture repair, it is possible that CXC signaling in
early fracture callus acts through one of these two mechanisms to facilitate successful repair.
Herein, we examine the role of CXC family receptor 2 (Cxcr2) in post-injury bone
formation through the use of transgenic mice and two models of skeletal fracture. We
hypothesize that knockout of Cxcr2 will impair fracture repair through either reduced neutrophil
recruitment and/or reduced angiogenesis.

5.2 Methods

5.2.1 Mice

All mouse studies were conducted under guidance of a Washington University IACUC
approved protocol. A total of 73 mice were used in this study. All mice were housed in 12:12
light/dark conditions, given water and food ad libitum. All mice were 12 weeks of age at time of
use and males and females were both used in these experiments. In order to study the impact of
CXC family signaling in bone regeneration we chose to target the knockout of CXC receptor 2
(Cxcr2), the common receptor for the CXC ligands upregulated in response to fracture. We
obtained Cxcr2 global knockout mice (Cxcr2 KO; gift from D. Link) [115] to test effects of
global knockout compared to wild type littermate controls. Cxcr2 KO and littermate wild type
controls were generated using breeders that were heterozygous for the Cxcr2 KO transgene.
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In order to examine if CXC signaling through immune cells is important in fracture repair,
we conditionally deleted Cxcr2 in myeloid derived cells by crossing the LysM Cre mouse
(Jackson Labs #004781) [168] to the Cxcr2 floxed mouse (Jackson Labs #024638) [169]. LysM
Cre+/+;Cxcr2fl/fl mice were used as experimental animals (LysM cKO) and were compared to
littermate LysM Cre+/+;Cxcr2+/+ control mice (LysM control). Experimental animals were
generated through the paired breeding of mice heterozygous for Cxcr2 floxed transgene (LysM
Cre+/+;Cxcr2+/fl). All mice were on a C57BL/6J background.

5.2.2 Full Fracture
Full fractures were created in the femur mid-diaphysis of mice (N = 43). Detailed
methodology for this procedure has been previously reported [44]. In brief, mice were kept under
anesthesia (isoflurane 1-3%) throughout the procedure. The right femur was exposed through an
incision and notched with a scalpel blade to predispose the mid-diaphysis to fracture. The right
hind limb was then secured in a custom fixture on a hydraulic material testing machine (Instron
Dynamite). A displacement controlled ramp (30 mm/s) was used to initiate three-point bending
of the femur to achieve fracture. The broken femur was then stabilized by insertion of a 24 G pin
inserted into the intramedullary space and the incision was closed. The left femur served as an
uninjured contralateral control. X-ray radiographs were taken at time of injury to ensure a break
at the mid-diaphysis and proper pin placement. Mice were then administered buprenorphine SR
(1 mg/kg, s.c.) and returned to their cages with unrestricted activity for 14 days until sacrifice.
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5.2.3 Stress Fracture
Stress fracture were created in the ulna diaphysis of mice (N = 30). Cyclic loading for stress
fracture creation has been thoroughly detailed in previous reports [88,89]. Briefly, while
anesthetized (Isoflurane 1-3%) the right forearm of the mouse is secured at the wrist and elbow
in custom fixtures on a hydraulic material testing machine (Instron Dynamite). Force controlled
cyclic loading at 2 Hz is performed until reaching a desired displacement at which a stress
fracture has formed. Loading parameters for each strain were determined using a set of
calibration animals to determine ultimate force of the forelimb and cyclic displacement to
complete fracture of the ulna and are listed in Table 5.1. The left ulna served as a contralateral
control. Mice were then administered buprenorphine (0.1 mg/kg, s.c.) and returned to
unrestricted cage activity until sacrifice.

Table 5.1: Stress fracture calibration data for Cxcr2 mouse strains.

Strain

Ultimate
Force
(N)

Cyclic Loading Displacement to Cyclic Stopping
Force
Fracture
Displacement
(N)
(mm)
(mm)

Cxcr2 KO (n = 8)

3.9 ± 0.4

2.9

1.13 ± 0.15

0.56

LysM cKO (n = 9)

4.4 ± 0.3

3.3

1.10 ± 0.36

0.55
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5.2.4 MicroCT

In order to evaluate baseline differences in the skeleton of wild type and Cxcr2 KO mice,
intact femurs were collected and scanned using microCT (Scanco VivaCT). Femurs were
scanned in air, with energy of 55 kVp, intensity of 145 μA, integration time of 300 ms, and voxel
size of 10.5 μm. Analysis of cortical bone was performed on 100 slices centered on the midpoint
of the femur length. Analysis of cancellous bone was performed on 100 slices in the distal femur
beginning proximal to the growth plate. Due to the smaller body size of Cxcr2 KO animals,
measurements were adjusted for body size using the linear regression method [170].
Similar approaches were used to evaluate fracture callus following full fracture or stress
fracture. For full fracture, femurs were dissected and scanned using same parameters as intact
femur scanning. Full fracture callus was analyzed for 600 slices centered on the fracture location.
For stress fracture, ulna were dissected and scanned using a Scanco MicroCT40 system in 3%
agarose, with energy of 70 kVp, intensity of 114 μA, integration time of 300 ms, and voxel size
of 10 μm. Stress fracture callus was analyzed for the entire length of the callus.
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5.2.5 Histology
Injured limbs were dissected and fixed for 24 hours in 10% buffered formalin. Injured bones
were then demineralized by EDTA 14% for 14 days. Samples were then embedded in paraffin
and sectioned at 5 μm transverse sections. Immunohistochemistry staining was performed using
an antibody for the neutrophil marker Gr-1 (Bio-Rad MCA2387T) at a concentration of 1:500
and an ImmPRESS reagent anti-rat kit (Vector Labs MP-7444). Slides were then imaged on a
slide scanner (Hamamatsu Nanozoomer) at 20X magnification. Quantification of stained cells
was performed with Bioquant software.

5.2.6 Deletion efficiency validation with qPCR
In order to test the knockdown efficiency of LysM cKO mice, bone marrow was collected
from left tibia of LysM cKO and LysM control mice, submerged in TRIzol, and stored at -80 C.
To extract RNA, TRIzol/sample solutions were processed with an RNA clean-up and
concentration kit (Norgen Biotek). cDNA was then produced (Bio-Rad iScript) using 500 ng of
RNA from each sample. qRT-PCR was performed (Applied Biosystems StepOnePlus) using
primers for Cxcr2 (IDT, F: AGC AAA CAC CTC TAC TAC CCT CTA, R: GGG CTG CAT
CAA TTC AAA TAC CA), and reference genes Tbp (IDT, Mm. PT. 39a. 22214839) and Ipo8
(IDT, Mm. PT. 39a. 22214844). Expression was normalized to reference genes and 2-ΔCt
expression values are reported.
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5.3 Results
5.3.1 Cxcr2 KO mice have smaller body size but comparable skeletons to wild
types
Cxcr2 knockout mice had smaller body weights than wild type control mice (Figure 5.1). A
2-way ANOVA of the cancellous and cortical bone parameters revealed significant genotype
effects for most parameters, with Cxcr2 KO having less bone than controls (Table 5.2).
However, due to significantly decreased body weight in Cxcr2 KO animals, skeletal
measurements were adjusted to account for body weight using the linear regression method
[170]. After body weight adjustments, genotype effects were only observed in a handful of
parameters (Table 5.2). Therefore, after accounting for reduced body size, Cxcr2 KO animals
develop normal skeletons.

Figure 5.1: Cxcr2 mice have lower body weights than wild type
contols. Body weights were measured at 12 weeks of age prior to injury.
Asterisk (*) denotes p < 0.05
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Table 5.2: Body weight adjusted values for MicroCT evaluation of baseline skeleton in Cxcr2 KO mice
Non-Adjusted

Body Weight Adjusted

WT

KO

Sig

WT

KO

Sig

BV/TV

24.8 ± 14.5

18.9 ± 7.7

*

21.0 ± 6.7

21.1 ± 4.5

ns

BMD

169.7 ± 87.8

130.1 ± 51.6

*

146.8 ± 41.2

145.4 ± 28.5

ns

Tb.N

8.3 ± 3.2

6.9 ± 2.2

*

7.4 ± 1.2

7.6 ± 1.1

ns

Tb.Th

0.057 ± 0.009

0.052 ± 0.005

*

0.055 ± 0.006

0.053 ± 0.005

ns

Tb.Sp

0.14 ± 0.05

0.17 ± 0.05

*

0.16 ± 0.02

0.15 ± 0.03

ns

Ct.Th

0.20 ± 0.02

0.18 ± 0.02

*

0.19 ± 0.01

0.18 ± 0.01

*

TMD

1022.8 ± 28.6

992.1 ± 62.0

*

1024.1 ± 28.2

1002.8 ± 54.2

ns

T.Ar

1.87 ± 0.32

1.86 ± 0.12

ns

1.78 ± 0.11

1.89 ± 0.09

*

B.Ar

0.89 ± 0.18

0.80 ± 0.10

*

0.84 ± 0.06

0.83 ± 0.05

ns

M.Ar

0.98 ± 0.15

1.05 ± 0.08

ns

0.94 ± 0.06

1.06 ± 0.08

*

pMOI

0.45 ± 0.17

0.40 ± 0.07

ns

0.40 ± 0.06

0.42 ± 0.04

ns

Cancellous

Cortical

Values represent group mean with standard deviation. Asterisk (*) denotes p < 0.05 genotype effect by 2-way
ANOVA.

5.3.2 Cxcr2 knockout does not impair endochondral ossification following full
fracture
Mice were subjected to full femur fractures and sacrificed following 14 days to observe
post-injury bone formation. MicroCT was used to analyze callus and bone formation (Figure
5.2). No significant changes were observed between wild type and Cxcr2 KO mice. Total callus
volume, bone volume, callus bone volume fraction (BV/TV), callus tissue mineral density
(TMD), and callus BMD were all consistent between wild type and knockout mice (Figure 5.2BF). Cxcr2 knockout mice produce equivalent callus and bone formation following full fracture.
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Figure 5.2: Cxcr2 knockout mice have normal full fracture callus formation. Full fractures were examined using
microCT at day 14 post-injury. 3D reconstructions of samples with median callus volume are depicted for each
group (A). Parameters such as total callus volume (B), callus bone volume (C), callus bone volume fraction (BV/TV)
(D), callus tissue mineral density (TMD) (E), and callus bone mineral density (BMD) (F) were measured. No
significant differences were detected in these parameters between wildtype and Cxcr2 knockout mice.
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5.3.3 Cxcr2 knockout impair intramembranous ossification following stress
fracture
Mice were sacrificed 7 days after ulna stress fractures and microCT was used to visualize
callus and bone formation (Figure 5.3). Crack extent was consistent between wild type and
knockout mice (Figure 5.3 B), representing equivalent damage burden produced by the model.
Woven bone (Wo.B) extent (Figure 5.3 C), measured as the longitudinal length of woven bone
callus, was also consistent between genotypes. The total callus volume and callus bone volume
were significantly reduced in knockout mice (Figure 5.3 D & E). Callus bone fraction (BV/TV)
was significantly increased in Cxcr2 KO mice (Figure 5.3 F). Callus bone mineral density
(BMD) was unchanged, but callus tissue mineral density (TMD) was significantly reduced in
knockout mice (Figure 5.3 G & H), suggesting that the bone in the callus was less mineralized in
knockouts. Cxcr2 knockout mice respond to stress fracture with reduced production of callus and
bone formation as compared to wild type controls.
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Figure 5.3: Cxcr2 knockout mice form smaller callus with less bone following stress fracture. MicroCT was
used to evaluate callus and bone formation 7 days after stress fracture. 3D reconstructions are shown for samples
with median total callus volume for each group (A). Crack extent (B) and woven bone (Wo.B) extent (C) were
comparable between groups. Cxcr2 KO mice formed callus with less total callus volume (D) and less bone volume
(E) than wildtype controls. Callus bone volume fraction (F) was increased in knockout mice. Callus bone mineral
density (BMD) (G) was unchanged between groups, but tissue mineral density (TMD) (H) was reduced in Cxcr2
KO mice. Asterisk (*) denotes p<0.05.
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5.3.4 Cxcr2 knockout impaired neutrophil recruitment to stress fracture
callus
Immunohistochemistry was used to stain stress fracture callus for Gr-1, a marker of
neutrophils. Wild type callus showed abundant staining for Gr-1, representing robust recruitment
of neutrophils as an immediate response (1 day post-injury) to stress fracture (Figure 5.4 A).
However, Cxcr2 knockout animals had little staining for Gr-1, representing deficient neutrophil
recruitment to the site of stress fracture injury (Figure 5.4 B). Quantification of Gr-1 staining
reveals a significant decrease in the cell density of Gr-1 positive cells in stress fracture callus of
Cxcr2 knockout mice (Figure 5.4 C).
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Figure 5.4: Cxcr2 knockout mice have reduced neutrophil recruitment after stress fracture.
Immunohistochemistry was performed on day 1 stress fracture callus using an antibody for Gr-1, a marker for
neutrophils. Representative images for a wildtype (A) and Cxcr2 KO (B) callus are shown. Quantifying the cell
density of neutrophils in the callus reveals significantly fewer neutrophils in Cxcr2 Ko callus (C). Scale bars are 100
μm length. Asterisk (*) denotes p<0.0001.
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5.3.5 LysM cKO mice do not phenocopy global knockout mice
Due to the reduction in neutrophils in the stress fracture callus of Cxcr2 KO mice, we
wanted to more closely examine if CXC signaling through neutrophils was responsible for the
reduced bone formation phenotype. To do this, LysM cKO mice were used to examine if
deletion of Cxcr2 in myeloid cells would result in a comparable diminished bone formation
following stress fracture as observed in Cxcr2 KO mice. Expression of Cxcr2 in bone marrow
was reduced by 68% (p < 0.0001) in LysM cKO mice as compared to control mice. In microCT
measurements of full fracture callus and stress fracture callus, LysM cKO mice had comparable
total callus volume and callus bone volume as compared to LysM control mice (Figure 5.5 B-E).
These results do not follow the same reduction in stress fracture total volume and bone volume
that is seen in the global Cxcr2 KO mice.
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Figure 5.5: LysM-Cxcr2 mice did not recapitulate the global knockout phenotype. Expression of Cxcr2 was
reduced by 68% in the bone marrow of cKO mice (A). Following full fracture, total volume (B) and bone volume
(C) of callus was consistent between groups. Following stress fracture, total volume (D) and bone volume (E) were
consistent between groups.
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5.4 Discussion
Following skeletal injury, ligands of the CXC chemokine family are highly upregulated,
suggesting they are involved in the inflammatory phase of fracture repair [28]. We set out to
explore the role of CXC family chemokines in bone fracture repair by using knockout mice
targeting the shared CXC receptor Cxcr2.
Cxcr2 knockout mice have a diminished capacity to form callus and woven bone
following stress fracture injury. Furthermore, Cxcr2 knockout mice showed reduced staining for
the neutrophil marker Gr-1, suggesting an inability to recruit neutrophils to the site of injury.
This lack of the earliest responding immune cell likely plays a role in the diminished repair
process, highlighting the important role of CXC family chemokines as some of the earliest
responders to skeletal injury.
We used Cxcr2 KO mice in order to study the role of the CXC family of chemokines on
post-injury bone formation. At 14 days following a femur full fracture, no difference was
observed in callus or bone formation between wild type and Cxcr2 KO mice (Figure 5.2).
However, 7 days following stress fracture, Cxcr2 KO mice have smaller callus, indicating a
reduced capacity for intramembranous repair (Figure 5.3), which is the predominant mode of
osteogenesis in stress fracture repair [6,89]. Crack burden was similar between groups, indicating
consistent damage burden created within the stress fracture model. Total callus volume and
callus bone volume were both significantly reduced in the Cxcr2 KO mice. However, woven
bone extent was unchanged between groups. This indicates that KO and wild type animals
display an equal capacity to form callus along the periosteal surface, and that Cxcr2 KO mice are
forming smaller callus due to reduced expansion of the callus away from the periosteum. Callus
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bone mineral density was increased in knockout mice. This is driven by total callus volume being
more greatly reduced than bone volume – resulting in increased volumetric bone density. On the
other hand, tissue mineral density was reduced in knockout mice – indicating that the woven
bone formed by knockout mice is less mineralized than wild type counterparts at this 7 day time
point.
A similar reduction in intramembranous bone formation has been reported in a model of
cranial defects by Bischoff et al [36]. They report Cxcr2 KO mice had 48% less bone ingrowth
within the defect site and a 54% reduction in vasculature within new bone matrix. However, it is
not evident why Cxcr2 KO does not interfere with post-injury endochondral ossification as seen
in the full fracture model.
Cxcr2 KO mice were found to have smaller body weights than control animals (Figure
5.1). After adjusting for smaller size, baseline skeletal features or cancellous and cortical bone
were comparable between Cxcr2 KO and control animals (Table 5.2). An earlier study by
Bischoff and colleagues [36] which reported a reduction in cancellous and cortical bone of Cxcr2
KO mice. However, this study did not adjust for reduced body weight.
We used IHC for the neutrophil marker Gr-1 to assess recruitment of immune cells to the
site of stress fracture 1 day after injury. Cxcr2 KO mice showed a greatly reduced potential for
neutrophil recruitment to the site of stress fracture than did wild type mice (Figure 5.4).
Neutrophils are the first responders of the immune system and play critical roles in wound repair
through their capacity to release important inflammatory cytokines [171–173]. A previous report
has shown that a reduction in neutrophil recruitment, as achieved through systemic antibody
treatment, is harmful for bone fracture repair [21]. Therefore, the inability for Cxcr2 KO mice to
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recruit neutrophils to the site of stress fracture injury is possibly a major contributor to reduced
bone formation.
Conditionally deleting Cxcr2 in immune cells using LysM Cre mice did not display the
same blunted response to stress fracture as did Cxcr2 KO mice (Figure 5.5). This might be
explained by deletion efficiency of Cxcr2 in neutrophils being less than 100%. Therefore,
although most neutrophils are unable to respond to stress fracture injury, enough do respond and
provide enough support to promote normal bone formation.
While histology demonstrations that neutrophil recruitment was greatly impaired by
global knockout of Cxcr2, we did not investigate if other mechanism may also be playing a role
in the reduced bone formation observed following stress fracture in these mice. Worth
investigating would be the role that Cxcr2 plays in angiogenesis. It has been reported that Cxcr2
on endothelial cells is an important moderator of cell recruitment and angiogenesis
[116,174,175]. It would be interesting to examine if this contributes to reduced bone formation
by limiting the recruitment of endothelial cells to stress fracture callus and thus limiting
angiogenic-osteogenic coupling which is vitally important to bone formation [166,167].
Also of importance might be to investigate the mechanisms through which neutrophils
are impacting fracture repair. Specifically of interest would be how levels of inflammatory
cytokines in the early fracture callus are impacted by Cxcr2 KO.
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In summary, we report that Cxcr2 KO mice have a reduced ability to form callus and
bone following stress fracture injury. This blunted bone formation is likely due to a disrupted
inflammatory phase, due to the inability of Cxcr2 KO mice to recruit neutrophils to the site of
injury. This work highlights the importance of a well-balanced inflammatory phase to successful
fracture repair and characterizes CXC family chemokines as contributors this phase.
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Chapter 6: Conclusions and Future
Directions

6.1 Conclusions
Bone possesses an impressive capacity for repair following skeletal injury. However, in
the clinic, fracture repair fails in up to 10% of patients [38]. This represents a fundamental need
for better understanding of the complex biology of fracture repair. Depending on the extent of
injury and mechanical stability of the injured bone, repair can occur through either
intramembranous formation, featuring direct formation of bone callus, or endochondral
formation, which features a cartilage intermediary callus [7]. We utilize two clinically relevant
injury models to initiate these bone formation cascades. Stress fractures are used to initiate
intramembranous bone formation and full fractures are used to initiate endochondral repair.
Using these models in combination with transgenic mouse models provide valuable insight into
the biology of fracture repair.
Successful fracture repair is contingent on the coordinated response of many different cell
types, signaling pathways, and biological processes. By more completely understanding the
events related to successful repair, we can more thoroughly understand how to best correct substandard repair. In order to better understand the biology of fracture repair, we used RNA-seq to
analyze the gene expression across several time points in models of intramembranous or
endochondral ossification.
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Intramembranous and endochondral bone formation were found to have distinct patterns
of gene expression. Endochondral ossification involved a greater number of differentially
expressed genes. An inflammatory reaction was present for both formation types, however
endochondral repair had expression of inflammatory genes and recruitment of immune cells that
were orders of magnitude greater than observed in intramembranous repair. Intramembranous
repair was more enriched for genes associated with osteoblasts and bone formation and
intramembranous repair was uniquely enriched for PI3K-Akt signaling. This is likely reflective
of more simplified nature of bone formation in intramembranous repair – which does not require
production of a cartilage intermediary callus. We also observed a dramatic downregulation of
voltage gated ion channels in endochondral repair, which was not present in intramembranous
repair.
The inflammatory phase of fracture repair is the initial response of the skeleton to injury
and promotes successful repair through the production of cytokines and the recruitment of
immune cells [8,9]. Interleukin-6 (IL-6) is a component of this inflammatory response and is
highly upregulated in response to skeletal injury. Despite its abundance in the early fracture
callus, how IL-6 influences fracture repair remains incompletely understood. Therefore, we
sought to examine the role IL-6 plays in fracture repair using two clinically relevant injury
models and IL-6 global knockout mice (IL-6 KO).
IL-6 KO mice developed normal skeletons and respond similarly to controls following
full fracture. But in response to stress fracture, IL-6 KO mice display an enhanced ability for
repair. IL-6 KO mice have larger calluses with more bone formation following stress fracture
than control animals. We investigated several mechanisms through which IL-6 may lead to
increased bone formation. There were no changes in osteoclast number or immune cell
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recruitment in IL-6 KO mice. Early gene expression was slightly altered and featured a
decreased inflammatory response and higher expression of Wnt1, a bone anabolic protein.
Furthermore, an examination of osteoblast function using a model for loading induced bone
formation revealed IL-6 KO osteoblasts to have an increased capacity for woven bone
production. In response to stress fracture, IL-6 appears to be an antagonist of bone formation and
global knockout of IL-6 increases callus production through slight alterations of inflammatory
gene expression and increased osteoblast matrix production.
The CXC family of chemokines are also highly upregulated as part of the inflammatory
phase of fracture repair. CXC chemokines signal through CXC family receptor 2 (Cxcr2) to
induce chemotaxis of cells, primarily neutrophils and endothelial cells [115,175]. But, the impact
of Cxcr2 on fracture repair has not been reported. To explore this, we utilized two clinically
relevant fracture models and Cxcr2 global knockout mice (Cxcr2 KO).
Cxcr2 KO mice had reduced body weights as compared to controls but developed
proportionally normal skeletons. Cxcr2 KO mice also had comparable callus formation following
full fracture. In response to stress fracture, Cxcr2 KO mice had a reduced capacity for repair –
displaying smaller calluses with less bone formation than control animals. Histology revealed a
substantial reduction in the recruitment of neutrophils to the site of stress fracture in Cxcr2 KO
mice. Therefore, we concluded that the CXC family of chemokines assist in post-injury bone
formation through recruitment of neutrophils during the inflammatory response.
Overall, this work provides insight into fracture repair and post-injury bone formation.
We were able to detail the transcriptomic profile of endochondral and intramembranous bone
formation across several time points. These data revealed several novel genes and pathways
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involved in fracture repair, including voltage gated ion channels in endochondral repair and
PI3K-Akt signaling in intramembranous repair. We hope this work can serve as a roadmap for
“normal” fracture repair, which can be a resource for planning future experiments on the genetic
contributors to bone formation.
Furthermore, we explored two components of the inflammatory phase of fracture repair.
In intramembranous bone formation following stress fracture, IL-6 KO was found to enhance
repair. On the contrary, Cxcr2 KO was found to decrease callus formation. These results
highlight the delicate balance of inflammation, which can serve as both a help and hindrance to
optimal fracture repair.

6.2 Future Directions
The work detailed in this dissertation provides insight into both the temporal gene
expression and the inflammatory reaction involved in fracture repair. However, as some
questions were answered herein, many others remain unanswered and could be intriguing topics
for future study.
In particular, the work describing the transcriptomics of fracture repair provides a
plethora of interesting follow up experiments. We found that the PI3K-Akt signaling pathway
was enriched throughout several time points in intramembranous repair. The role of this pathway
in osteogenesis is not completely understood. Assessment of this pathway in stress fracture repair
could be of importance to the field. Using pathway antagonists and agonists, experiments could
be designed to measure the impact of PI3K-Akt signaling on bone formation.
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Another finding from the transcriptional profiling was the potent down regulation of
voltage gated ion channels during endochondral repair. There are not many reports regarding the
role of ion channels in bone repair. Therefore any investigation into the systematic
downregulation of ion transporters in endochondral repair would be illuminating. Ion channel
antagonists and agonists could be used to stimulate ion channels during fracture repair and bone
formation could be measured.
Through investigations of IL-6, we were able to reveal IL-6 KO led to increased bone
formation after stress fracture. Several follow up experiments could be potentially enlightening.
Firstly, in an attempt to identify the cellular source of IL-6, we were unable to recapitulate the
increase bone formation phenotype using conditional deletion of IL-6 with LysM or Osteocalcin
Cre lines. This indicates that either we targeted the wrong population of cells for deletion, or that
IL-6 is produced by several cell types. An experiment to measure IL-6 expression by qPCR in
stress fracture callus of LysM and OC cKO mice could answer what proportion of IL-6 is
supplied by each cell population. Depending on the results, this experiment could also explain
the lack of phenotype in these mice, especially if compensating sources of IL-6 prevent a
dramatic decrease in IL-6 production. It would also be possible to attempt these stress fracture
experiments again using different Cre lines. One interesting target would be osterix Cre, which
would cast a wider net than OC Cre and target all bone cells in the osteoblast lineage from
progenitors to mature osteocytes.
Another interesting question involves identifying the cell population which is responding
to IL-6 in stress fracture repair. Our experiments, which reveal increased woven bone production,
suggest that osteoblasts are responsive to IL-6 signaling, and thus IL-6 KO. It could be
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interesting to conditionally target the osteoblast lineage for IL-6 Receptor deletion and observe if
increased bone formation occurs after stress fracture.
We found decreased stress fracture repair capabilities in Cxcr2 KO mice. However, a
more thorough examination of these mice should be completed. Cxcr2 is known to facilitate the
chemotaxis of both neutrophils and endothelial cells. We were able to show through histology
the reduced potential for neutrophil recruitment to the stress fracture callus of Cxcr2 KO mice.
However, we did not investigate the possibility of diminished angiogenesis from reduced
endothelial cell migration. One experiment to test angiogenesis would be histology staining for
endomucin, a marker for endothelial cells. If Cxcr2 stress fracture callus showed reduced
staining of endomucin relative to callus size, it could be concluded that reduced bone formation
after stress fracture is caused by reductions in both neutrophil and endothelial cell recruitment.
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